Entities

Patrick Miles is published by InnovaHealth Partners as Strategic Advisor (published affiliation). Orthopedic technology executive with Alphatec Spine leadership and earlier NuVasive, Medtronic and Smith & Nephew experience. This is a published advisory affiliation with InnovaHealth, not an employee or individual investor ticket.

Thomas Kean is published by InnovaHealth Partners as Strategic Advisor (published affiliation). Former New Jersey governor, Drew University president and chair of the9/11Commission, with healthcare and philanthropic governance experience. The directory’s outside organization titles are treated as source-published background.

Lisa Granick is published by InnovaHealth Partners as Strategic Advisor (published affiliation). Healthcare market and investment-diligence strategist with experience in cardiovascular, neurosurgical, orthopedic and women’s-health technologies. Earlier roles include Boston Consulting Group and Motorola.

Yves-André Istel is published by InnovaHealth Partners as Strategic Advisor (published affiliation). Investment-banking veteran whose published background includes Hanseatic and Rothschild. Outside directorships mentioned in the manager biography may be historical and are not independently represented as current employment.

Emme Deland is published by InnovaHealth Partners as Strategic Advisor (published affiliation). Healthcare strategist with NewYork-Presbyterian, Mount Sinai and Brigham and Women’s experience. Her own foundation biography distinguishes the chief-strategy-officer position held beforeOctober2020 from later strategy-advisor work; obsolete outside titles on the manager directory are not treated as current appointments.

Tony Chou is published by InnovaHealth Partners as Strategic Advisor (published affiliation). Physician and medical-device entrepreneur with Route92Medical and The Vertical Group experience. The directory identifies an advisory affiliation, separate from investing staff or a personal cash ticket. Tony Chou is Founder and Chief Executive Officer at Route 92 Medical. Physician and medical-device entrepreneur with interventional cardiology training and former faculty and catheterization-laboratory leadership at UCSF. His operating background includes Abbott Vascular and investing at The Vertical Group. The Vertical Group publishes Tony M. Chou as a general partner. His medical-device operating background includes Abbott Vascular and cardiology at UCSF. He studied medicine at Case Western Reserve and physics and electrical engineering at Carnegie Mellon. Existing Route92 CEO and InnovaHealth advisory affiliations are preserved; these roles do not establish a personal investment check.

Natalia Stricker is published by InnovaHealth Partners as Executive Assistant. Manages New York office operations and coordinates research. Her earlier communications and public-affairs work involved international agriculture organizations in Paris; her education includes ISMaPP and Université de Nice Sophia-Antipolis.

Ariella Golomb is published by InnovaHealth Partners as Senior Advisor. Physician and investment strategist with earlier HealthpointCapital and Boston Consulting Group experience. She holds a University of Pennsylvania MD and Wharton MBA; current own-directory title Senior Advisor supersedes the webpage’s old Managing Director browser title. Ariella Golomb is Director at Route 92 Medical.

Noah Pereles is published by InnovaHealth Partners as Associate. Supports investment diligence, financial models, market research, portfolio monitoring and fundraising. Earlier corporate-development and M&A work at Sodali & Co followed consulting at Management Solutions; he earned an economics degree at Wharton. Current Associate title supersedes the old Senior Analyst browser title.

Tiffany Cheynier is published by InnovaHealth Partners as Senior Manager - Investor Relations and Marketing. Communications and marketing professional responsible for investor relations and fundraising. Her background includes Lazard strategic planning and HealthpointCapital investor communications; she holds a Columbia master’s degree.

Toby Cosgrove is published by InnovaHealth Partners as Senior Partner. Cardiothoracic surgeon and medical innovator who led Cleveland Clinic as President and CEO from2004 to2017. His clinical and healthcare leadership experience supports the manager’s medical-technology investments.

Lord Hugo Swire chairs BOKA’s investment committee. He previously represented East Devon in the UK Parliament and served as a minister at the Foreign and Commonwealth Office and Northern Ireland Office. His experience includes public and private company boards and international relations.

Kaspar Varmuza joined BOKA in 2023 and serves as chief of staff. His background includes strategic planning, UK government defense liaison and military operations. He formerly served as a major in the Grenadier Guards.

Niklas List joined BOKA in 2022 as a partner. He previously worked in mergers and acquisitions at Goldman Sachs, in corporate finance at MorphoSys and at Armira Partners. His experience includes strategic acquisitions, financing and venture transactions.

Grant Hume joined BOKA in 2024 as an operating partner. He previously worked at Amazon Web Services in national security, defense and space and held leadership roles at ForceSelect and IBM. He formerly served as a British Army lieutenant colonel.

Cole Crawford is a BOKA operating partner and chief executive officer of Vapor IO. His background includes co-founding the Open19 Foundation, leading the Open Compute Project and contributing to OpenStack and open cloud infrastructure.

Lord Henry Bellingham chairs BOKA’s advisory board. A former barrister and UK parliamentarian, he previously served as a minister responsible for African affairs. He advises on geopolitical risk, sovereign engagement and policy relevant to defense and technology investments.

Erik Thoresen joined BOKA in 2022 as a partner and served on Infleqtion’s board from 2022 through its 2026 NYSE listing. He previously worked at Calaveras Capital, BNY Mellon Wealth Management, E*TRADE Financial and the U.S. Trade and Development Agency. He is a CFA charterholder and holds an MBA from the University of Virginia’s Darden School. His former Infleqtion board role does not establish current directorship.

Teresa Smetzer is a BOKA operating partner. She previously led national-security programs at Salesforce and founded consulting businesses supporting government and industry, drawing on experience in intelligence and technology.

Rich Julien joined BOKA in 2024 as an operating partner. His experience spans technology, analytics, operations and program leadership across government and commercial organizations.

Lieutenant General Dennis Gyllensporre is a BOKA senior advisor and retired Swedish military officer. He has held senior military and international leadership appointments and advises the firm on defense and security.

Sir James Cleverly is a BOKA senior advisor with experience in foreign policy, domestic security and allied cooperation. His prior UK government roles include Foreign Secretary and Home Secretary. The firm’s current biography identifies him with parliamentary and reserve-service honors; those do not establish a personal venture investment.

John Kennedy co-founded BOKA in 2022 and serves as managing partner and group chairman. His investing and entrepreneurial background includes real estate, infrastructure and economic development. He is distinct from similarly named political and historical figures.

James Tennant joined BOKA in 2024 and leads its Asia-Pacific activities as a partner. He previously worked in investment banking at VCA Partners and LightHorse Group and was a senior partner at Gilmour Space Technologies. His experience spans quantum, AI, space, cybersecurity and autonomous systems.

Dame Penny Mordaunt is a BOKA senior advisor. Her previous UK government roles include Secretary of State for Defence, Leader of the House of Commons and Secretary of State for International Development. She advises on defense policy, procurement and allied security priorities and previously served in the Royal Naval Reserve.

General Sir Peter Wall is a BOKA senior advisor and retired British Army general. He formerly served as Chief of the General Staff and advises on defense leadership, technology adoption and national security.

Joanne Isham is a BOKA senior advisor with experience in defense technology and intelligence leadership. She previously held senior roles at BAE Systems, High Performance Technologies and L-1 Identity Solutions, and served as deputy director of the National Geospatial-Intelligence Agency and CIA deputy director for science and technology. She helped establish In-Q-Tel.

Rasmus Fogelstrøm joined BOKA in 2025 as an associate. He previously worked in investment banking at Goldman Sachs and UBS and in strategy at Maersk. He formerly served in the Royal Danish Army and studied international finance at HEC Paris.

Lieutenant General Sir Ian Cave is a BOKA senior fellow and retired British Army officer. He served as the United Kingdom’s military representative to NATO and the European Union from 2023 to 2026 and previously led Home Command. His BOKA fellowship is distinct from an investment-partner appointment.

John James founded BOKA in 2022 and serves as managing partner and group chief executive officer. He served on ALL.SPACE’s board from 2023 through its 2026 combination with York Space Systems. He previously led Fusion Acquisition Corp., co-founded ScalaMed and founded BetaSmartz. He is an Atlantic Council nonresident senior fellow focused on technology, defense and geopolitics.

10K Lakes Capital LLC is a Bloomington, Minnesota alternative investment manager founded in 2020 by members of SightLine Partners. Its own website identifies SightLine as a sister company, and current SEC filings list 10K Lakes as a separate relying adviser under SightLine’s umbrella registration. It structures secondary purchases, portfolio reorganizations and follow-on financing across private-company equity, debt and limited-partnership interests, with a focus on healthcare. The current public directory publishes seven team members. Regulatory filings document five numbered 10K Lakes funds: FundI and FundII fully sold USD26 million and USD106.7 million offerings respectively; FundIII disclosed USD57.5 million sold toward USD88.5 million in March2024; FundV reported USD275,853,391 sold in June2025. FundIV is a verified legal fund whose fundraising amount remains unverified. More than USD1billion of shared committed capital and over200 transferred portfolio positions describe the combined historical platform and are not new fund closes or company cash rounds.

SightLine Partners LLC is a Bloomington, Minnesota healthcare investment manager and SEC-registered adviser, CRD162629 and SEC801-80007. It became independent in 2004 by acquiring the healthcare venture-capital operations of Piper Jaffray, whose venture platform began in 1992. SightLine manages special-situation healthcare funds, investing in private medical technology, diagnostics and life-sciences businesses and providing secondary liquidity to existing investors. It co-led Monteris Medical’s 2017 Series C financing for MRI-guided neurosurgical laser ablation. Its fully sold Healthcare Opportunity Fund II reported USD107,359,422 in aggregate across the main and parallel issuers in August2013. 10K Lakes Capital LLC is a separately identified sister company and relying adviser under SightLine’s SEC umbrella, formed in 2020; the SightLine domain now redirects to its shared public website. Shared biographies and regulatory filings support six current SightLine affiliations. The website’s separate 10K Lakes roles are qualified accordingly, and are not presumed SightLine employment. Historical fund holdings, aggregate firm commitments and current AUM are distinct from new operating-company fundraising.

Vice President of Finance in the shared SightLine Partners and 10K Lakes Capital directory. Joined SightLine in 2012 and supports fund accounting, reporting, administration and transactions.

Co-founder of SightLine Partners in 2004 and 10K Lakes Capital in 2020. Established Piper Jaffray’s healthcare venture platform in 1992 and later developed SightLine’s healthcare secondary-investment strategy.

Chief Financial Officer and Chief Compliance Officer at 10K Lakes Capital, joining in 2024, and SightLine Partners’ Chief Compliance Officer in current SEC filings. Minnesota CPA with accounting, reporting and compliance experience.

Venture Partner affiliated with SightLine Partners and 10K Lakes Capital. Previously served as a Managing Director at Split Rock Partners, investing in healthcare businesses.

Managing Director and co-founder of 10K Lakes Capital, with SightLine Partners investment responsibilities since 2012. Previously held operating roles in Boston Scientific’s cardiac-rhythm-management business.

Senior Associate in the shared SightLine Partners and 10K Lakes Capital directory. Joined 10K Lakes in 2020, supporting diligence, fundraising and portfolio management; studied financial markets at the University of Minnesota Duluth.

Managing Director at 10K Lakes Capital since joining in 2025. Previously led business development at Shockwave Medical and Boston Scientific, and was a Partner at Endeavour Vision.

Advisor on the Borusan Ventures Investment Committee. Following graduation from NYU in 2021, he worked in renewable energy engineering at Borusan EnBW Energy and EV charging strategy for BORENCO. Appointment dates for the venture committee are not publicly established.

Advisor on the Borusan Ventures Investment Committee. His published biography describes Borusan Group audit board and holding company board responsibilities, experience in steel pipe and automotive businesses, and founding Borusan Otomotiv Motorsport.

Advisor to Borusan Ventures with corporate venture, robotics and energy investing experience. Previously CEO of TotalEnergies Ventures and founder and president of ABB Technology Ventures, with earlier GE Capital, United Healthcare and startup operating roles. Other firms’ stated capital amounts are distinct from Borusan venture capital.

Advisor to Borusan Ventures. Her published biography describes Borusan group strategy leadership across business development, mergers and acquisitions and digitalization, with more than twenty years of experience spanning telecommunications, logistics, energy, machinery and steel.

Borusan Group chief executive, whose corporate leadership biography is published on the Borusan Ventures team page. The biography says he became group CEO in 2020 following executive committee responsibilities and eleven years leading Borcelik. This is group corporate leadership, not an appointment as CEO of Borusan Ventures; the public detail modal does not establish a venture investment staff position.

Venture Development Advisor to Borusan Ventures, supporting strategic partnerships between startups and Borusan Group businesses, deal sourcing and diligence. His published biography describes more than ten years of strategy, business development and mergers and acquisitions experience, including Borusan group strategy work.

Associate at Borusan Ventures responsible for sourcing, opportunity evaluation, due diligence and market research. Previously a Borusan Holding management trainee and a strategy and business development specialist.

Founder and Chair of Borusan Ventures, actively involved in venture investment activities. Her career spans Borusan steel pipe, automotive and heavy machinery businesses. The firm’s published biography also identifies her as Borusan CAT chairperson and board member of Borusan Otomotiv and Borusan Pipe.

Managing Partner and head of Borusan Ventures, leading strategy, operations and investments. Previously a principal at Yamaha Motor Ventures investing in mobility, logistics, robotics, data and AI, after roles with Sony Innovation Fund and JetBlue Technology Ventures. Historical employer assets under management do not describe Borusan’s fund size.

Ajay Nanda is Managing Director at Oxford Finance LLC.

Amanda Stern is Director of Marketing at Oxford Finance LLC.

Austin Szafranski is Executive Director at Oxford Finance LLC.

Brock Johnson is Managing Director at Oxford Finance LLC.

Charles Boyle is Senior Director at Oxford Finance LLC.

Daniel Fisher is Executive Director at Oxford Finance LLC. He underwrites and executes leveraged lending transactions in healthcare and business services. He joined Oxford in 2015 after Alliance Partners and Fannie Mae, studied at Virginia, and holds the CFA designation.

Dave Laman is Senior Director at Oxford Finance LLC.

Desirée Williams is Associate General Counsel at Oxford Finance LLC.

Dorin Fachiol is Senior Director at Oxford Finance LLC.

Eric Schwartz is Executive Director at Oxford Finance LLC. He oversees healthcare real estate underwriting after earlier credit and portfolio roles at Omega Healthcare Investors and PNC. He studied financial economics at UMBC.

Eric Veale is Senior Director at Oxford Finance LLC.

John Toufanian is General Counsel and Chief Legal Officer at Oxford Finance LLC.

Joseph Somerset is Managing Director, Portfolio Management at Oxford Finance LLC.

Kevin Smith is Senior Director at Oxford Finance LLC. He joined Oxford in 2018 and underwrites and manages life-sciences senior debt. Earlier finance work included Medley Capital; he studied chemical engineering and economics at UCLA.

Krister Anderson is Senior Director, Portfolio Management at Oxford Finance LLC.

Kush Patel is Senior Director at Oxford Finance LLC.

Laurel Wittman is Managing Director, Head of Special Situations at Oxford Finance LLC.

Mark Davis is Vice President, IT and Administration at Oxford Finance LLC.

Mark Hirsh is Managing Director at Oxford Finance LLC.

Maryam Zafar is Chief Legal Officer, Enterprise Lending and Deputy General Counsel at Oxford Finance LLC.

Nick McDearis is Managing Director at Oxford Finance LLC.

Patrick McLenahan is Executive Director, Portfolio Management at Oxford Finance LLC.

Peter Dahms is Managing Director at Oxford Finance LLC.

Phil Tonucci is Managing Director at Oxford Finance LLC.

Rafal Rydzewski is Senior Director at Oxford Finance LLC.

Richard Russakoff is Managing Director at Oxford Finance LLC.

Ryan Haight is Executive Director, Portfolio Management at Oxford Finance LLC.

Sunil Annapareddy is Managing Director at Oxford Finance LLC.

Tanzeer Khan is Managing Director at Oxford Finance LLC.

Christopher Herr is Executive Managing Director at Oxford Finance LLC.

Colette Hastings Featherly is Senior Managing Director and Executive Vice President at Oxford Finance LLC.

David Hickman is Managing Director, Co-Head of Enterprise Lending at Oxford Finance LLC.

Garrett Henn is Managing Director, Co-Head of Enterprise Lending at Oxford Finance LLC.

Hans Houser is Chief Investment Officer and Senior Vice President at Oxford Finance LLC.

J. Alden Philbrick IV is Executive Chairman and Founder at Oxford Finance LLC. He previously established Oxford Venture Finance and served in executive leadership at equipment lessor Finalco. He studied management science and public policy at Duke.

Joshua Friedman is Chief Financial Officer at Oxford Finance LLC. He leads corporate finance, planning, treasury and accounting, and oversees ABS issuance and private borrowing. He joined Oxford in 2011 after MCG Capital and holds the CFA designation.

Kevin Harbour is Managing Director at Oxford Finance LLC.

Kirk Andrews is Managing Director at Oxford Finance LLC. He evaluates and manages life-sciences senior credit facilities. He joined Oxford in 2011 after advisory work at SFRi and studied at Franciscan University.

Timothy Bernier is Senior Managing Director at Oxford Finance LLC. He returned to Oxford in 2015 after work at Wells Fargo, Saints Capital and Deutsche Bank. He studied finance at Georgetown and holds the CFA designation.

Timothy Lex is President and Chief Executive Officer at Oxford Finance LLC. His earlier leadership includes Sallie Mae’s thrift division and Riggs Bank. He studied economics at William and Mary and holds an MBA from Rochester.

Tracy Maziek is Executive Managing Director, Leveraged Lending, Real Estate and ABL at Oxford Finance LLC. He leads leveraged lending, healthcare real estate and asset-based finance. He returned to Oxford in 2015 after leadership in healthcare finance at Wells Fargo, with earlier Siemens and FINOVA experience.

BOKA Group is a deep-technology investment firm focused on advanced computing, artificial intelligence, quantum technology, autonomy, space and national security. It provides patient capital and operational support to growth-stage companies developing commercial and defense applications, with a stated focus on allied capability and sovereign resilience. Its own directory lists investment professionals, managing partners, operating partners, senior fellows and an advisory board; advisory and military-policy experience does not establish a separate personal investment. The firm publishes offices in New York, Washington DC, Austin, Boulder, London, Sydney and Abu Dhabi. BOKA Capital is a group brand, and BOKA Capital Ltd is a UK group member and appointed representative of Robert Quinn Advisory LLP. The firm’s portfolio disclaimer says published investments span multiple products and vehicles. BOKA Group Holdings I LP and BOKA Group Holdings GP LLC appear in Infleqtion’s primary ownership filings; securities holdings do not establish a completed investment-fund capital raise. BOKA’s February2026 announcement confirms participation in Infleqtion’s completed PIPE, and describes its earlier USD35M anchor investment in the 2022 Series B. Portfolio relationships include quantum computing and sensing, satellite communications, spacecraft propulsion, maritime autonomy, semiconductor manufacturing and audio technology. No public fund-close total is asserted from AUM, portfolio valuation, or stock ownership. A newly filed BOKA Growth III, L.P. offering reported no first sale, zero proceeds and zero investors as of its October1,2026 SEC notice; its USD5M minimum subscription is not a fund raise. Current founder biographies date the deep-technology platform to2022, while an older SEC biography describes John James’s separate earlier Boka emerging-market fund activity beginning2005 and ending2010; legal continuity and additional historical fund amounts are not inferred.

Mark is a Partner at Index Ventures, investing across all stages in cybersecurity, infrastructure, and AI. He looks to partner with technical founders who demonstrate exceptional degrees of domain expertise, hustle, and customer obsession.Since joining Index, Mark has backed and partnered closely with founders building at the frontier of AI, including Flapping Airplanes, Simile, Fireworks, Parallel, and 7AI. Prior to Index, he was a growth investor at Lightspeed, where he supported companies like Wiz, Glean, and Grafana. He studied mathematics, economics, and computer science at Harvard and before that played violin at Juilliard.Originally from Boston, Mark grew up in Connecticut and now lives in NYC. He enjoys being a Boston sports fan, playing pick-up basketball and squash, being a foodie, and obsessing over new health trends.

Zack Urlocker is an Executive in Residence at Index Ventures, where he partners with portfolio companies on go-to-market strategy and execution.Zack has a long history with Index-backed companies, having held senior leadership roles at three of the firm’s most successful investments over the past two decades. As COO at Duo Security, he helped scale the business leading up to its $2.35 billion acquisition by Cisco. At Zendesk, he guided the company’s growth as COO. Earlier, as EVP of Products at MySQL, he built the subscription business model, which led to a $1 billion acquisition by Sun Microsystems.Beyond his operating roles, Zack has advised and served on the boards of numerous enterprise software companies, supporting founders as they expand globally and build world-class go-to-market organizations. He is a frequent speaker on scaling technology companies and writes regularly at www.buildtoscale.substack.com.Zack is a reformed marathon runner, road cyclist, occasional bass player, and is using AI to develop a graphic novel adaptation of his noir detective novel “The Man from Mittelwerk.”

Joe is VP of Europe Legal at Index and joined the team in 2021.Prior to joining Index, Joe spent four years at Bird & Bird in London, working with businesses that are disrupting traditional sectors through innovative developments in technology. He has represented investors and founders, allowing him to build relationships on both sides of the table.Joe began his legal career at HSF as a corporate associate, concentrating on M&A, private equity transactions and corporate reorganisations.

Georgia focuses on AI-native products and research companies. She partners closely with companies including Granola, Ineffable & Mirelo.She is particularly interested in how AI will drive different behaviours, and unlock new ways to live & work.She started her career in the early days of Deliveroo, doing door-to-door sales to restaurants and launching the business in new markets. Georgia graduated from St John’s College, Cambridge with a degree in History.

Weronika is a VP, Regulatory and Compliance at Index in London, looking after regulatory and compliance matters across investments, fundraising and Index's day-to-day operations, as well as data protection and sustainability.Prior to joining Index, Weronika spent six years at Norton Rose Fulbright (NRF) where she covered financial services (FS) regulatory compliance and qualified as a regulatory lawyer. During that time, she also worked at NRF’s Tokyo office and Goldman Sachs. Before NRF, Weronika worked as a financial crime research analyst advising senior managers in the FS sector on law, regulation and best practice in the financial crime space.

As a Partner at Index, Hannah focuses on B2B software and enterprise AI applications. She works with founders who are reshaping every sector of the economy by digitising workflows, automating manual processes, and transforming the services sector at large.In close to a decade at Index, she has built a track record of helping visionary entrepreneurs from day one, and supporting them as their companies scale. She is particularly energized by founders who leverage technology to tackle daunting problems in large and traditional sectors that were previously deemed too hard to tackle. Her investments at Index include DataSnipper, who supercharge auditors; Remote, a platform to hire, manage and pay global teams; Multiverse, the company bringing apprenticeships into the digital age; and Fonoa, tax technology for global businesses.Before joining Index, Hannah managed the consumer marketplace business for Ebay in the UK, and set up the General Merchandise business for Ocado. She holds an Economics degree from the University of Cambridge.

Shardul invests in cybersecurity, AI, enterprise software, and infrastructure. Since joining Index in 2008, he has led early investments in category-defining companies, including Datadog (NASDAQ: DDOG), Wiz, Simile, and Parallel, where he currently serves on the board.Over the years, Shardul has worked closely with founders to drive meaningful outcomes at companies such as Wiz (Google), Adallom (Microsoft), Base (Zendesk), Brightback (Chargebee), Duo Security (Cisco), Gatsby (Netlify), Koality (Docker), Lacoon (Check Point), Nginx (F5), Reclaim (Dropbox), Signal Sciences (Fastly), and SourceClear (CA Technologies).Widely recognized as one of the leading investors in cloud infrastructure, Shardul has been named to the Forbes Midas List multiple times. His investment philosophy is anchored by three principles: 1) It’s all about the founder; 2) Invest with extreme conviction; 3) Operate with intentionality—go big or go home.Shardul began his career at Summit Partners after graduating from the University of Chicago. He lives in New York City with his wife and children.

Sandra is a global talent executive who focuses on the complex relationship between recruitment, culture and organizational strategy. She serves as a collaborator and thought partner to Index founders during the growth and scale-up phases, advising on all talent-related matters and connecting them to the best C-Suite and Board talent in Europe. Sandra is particularly committed to diversity in hiring, and to expanding and refining the definition of ‘professional excellence’. She is dedicated to helping people to see potential in themselves that they might not yet recognise, and in matching those capabilities to the needs of high-growth businesses.Before joining Index, Sandra worked at Russell Reynolds, where she advised global companies on digital and technology leadership, hiring, culture and diversity. Previously Sandra led the people, security and facilities functions at the Open Society Foundations, George Soros’ $20 billion philanthropic vehicle, where she conceived and created its global people policies and operations.Sandra was also the director of career services at INSEAD, a leading global business school based in France, where she led on the strategy and execution of career offerings for the MBA students and alumni – overseeing growth from 1,000 to 55,000 stakeholders.Sandra holds an Executive Master in Change from INSEAD, and is a graduate of Sciences Po Paris and the University of London.

Katie serves as an advisor and thought partner to founders as they build out their foundational leadership teams, helping with strategy and calibration. She also spends time growing Index’s technical talent network, building meaningful relationships with top engineering and product leaders in the US.Prior to joining Index, Katie spent over 8 years at Stripe where she helped create and lead the global Recruiting function. Katie joined when Stripe was 200 people as its first Tech Recruiter, expanded its Singapore office and APAC presence and spent the last few years running its Executive Recruiting team, supporting the company as it reached over 8,000 employees. Prior to Stripe, Katie also spent time recruiting top talent and building teams at Google and Yahoo.Katie has her degree from UC Santa Barbara and spent her childhood and the last few years in Southern California. Now back in San Francisco, outside of work she can be found at the beach with her two children, husband and labrador, watching football or planning her next trip to the mountains.

Emil works with growth-stage businesses across industries and geographies, supporting founders in scaling category-defining companies.Prior to joining Index, he was at KKR Tech Growth in London and began his career at Picus Capital. Emil holds an MSc from the London School of Economics and a BSc from the University of Amsterdam.A former professional field hockey player, Emil is a lifelong sports enthusiast who brings the same energy and competitive spirit to investing and helping founders win.

Jahanvi Sardana is an early-stage and growth investor at Index Ventures in New York, where she partners with founders building category-defining companies in AI, enterprise software, healthcare, and financial services. Since joining Index she has led investments across these categories and serves on the boards or works with companies including Sublime Security, Thatch, Crosby Legal, and others.Her investment philosophy is simple: invest for strength, not for the absence of weakness. “In the end, I think amazing success can be achieved by highly imperfect people,” she says. “What matters is finding alignment in values and conviction in a founder’s spike, an area of extreme competence or insight that will give them unfair advantage. The rest we can work on together.”Before Index, Jahanvi invested at Stripes, backing companies like Island, Axonius, Lithic, and Oyster. She holds a B.S. in Finance and Business Analytics from The Wharton School at the University of Pennsylvania.

Susana joined Index in 2023 and invests in AI, healthcare, and application software in NYC. Susana is excited to partner with gritty entrepreneurs obsessed with solving big problems in massive markets.Prior to joining Index, Susana was an investor at Picus Capital and before that, an investment banker at Goldman Sachs. She holds a B.S. in Finance and Business Analytics from The Wharton School at the University of Pennsylvania where she graduated summa cum laude.Susana is originally from Colombia and enjoys cycling, skiing, yoga, climbing & house music.

Neil is a Retired Partner at Index Ventures. He co-founded Index Ventures in 1996 and served as a Partner for more than 25 years. In 2021, Neil stepped down as an active Partner. Since then, he has continued to manage his portion of the portfolio and makes himself available to support his partners and the firm he helped build.As an investor and a founder, Neil has played a seminal role in nurturing the tech ecosystem in Europe and beyond. He is passionate about mentoring and partnering with founders who possess a strong sense of purpose. Neil led the firm’s investment in a number of enduring companies including Betfair (Flutter), Genmab, Stepstone, Climate Corporation, Supercell, Trello, Typeform, Nexthink, Funding Circle, Stack Overflow, Revolut and Roblox. Born in Montreal, Neil studied at Stanford and earned his MBA from Harvard Business School. He spent four years with Montgomery Securities in San Francisco, and joined Index Securities in 1990 — the predecessor of Index Ventures. Neil is Co-Chair of the board of Human Rights Watch.

Danny Rimer is an investor and partner at Index Ventures. He opened the firm’s London office in 2002 and the San Francisco office in 2012, before returning to London in 2018. He has been ranked by Forbes as one of the world’s top investors for over a decade.Danny has always been drawn to working with founders who share his passion for the power of design and his fascination with the intersection of technology and culture. This has informed investments in Figma, Dropbox, Discord, Etsy, Farfetch, Glossier, Patreon and many more. Of his role as an investor, he says: “Our job is spotting someone trying to spark lightning in a bottle working out of their garage and we have to figure out whether they’re the right people to do this, that they have been placed on this Earth to go after this global ambition. We then work tirelessly to help them get there.”Danny’s interest in technology began when he moved to the West Coast at the birth of Web 1.0 in the 90s. Taking a job as an underwriting analyst at Hambrecht & Quist (now owned by JP Morgan), Danny established the boutique investment bank’s internet sector equity research group and worked on the IPOs of Amazon, Netscape, Verisign and more. It was this experience that ignited a desire to work directly with those building companies, and he soon became a General Partner at The Barksdale Group in 1999, before moving to Index three years later.

Simon partners with early-stage founders across industries and geographies, backing ambitious teams from day one.Prior to joining Index, Simon was an early-stage investor at RTP Global and Entrepreneur First's first investor in the US, where he launched cohorts in both New York and San Francisco. He also co-founded Delph, a platform enabling citizens to support political campaigns and nonprofits through NFTs. He holds degrees from the London School of Economics and Yale University.Originally from France, Simon has now become a true New Yorker, you might find him training for his next race on the west side highway, playing bughouse at the chess forum or reading biographies in Washington Square Park.

As VP of Community and Events at Index Ventures, Khalehla leads the firm’s global efforts to shape how founders, operators, and investors experience Index. She and her team create thoughtfully designed, in-person gatherings that bring the Index brand to life and deepen connections across its worldwide network. With a sharp eye for design, food, and craft, Khalehla curates partnerships with exceptional chefs, makers, and creative collaborators - ensuring every Index experience reflects the firm’s taste, values, and spirit of hospitality.Before joining Index, Khalehla led f.ounders at Web Summit, convening a global network of entrepreneurs. She later spent six years at BCG Digital Ventures in London and New York, running global strategic partnerships and collaborating with the World Economic Forum, The New York Times, The Financial Times, and The Milken Institute.Khalehla graduated with honours from Trinity College Dublin, earning a dual degree in History of Art and Architecture, and Sociology, where her research explored how people and communities interact with their designed environments.

Carleigh serves as an advisor and partner to founders and leaders for their Go-To-Market talent strategies. Additionally, Carleigh focuses her time nurturing and growing the Index network with exceptional GTM leadership in the US. Prior to Index, Carleigh spent nearly a decade at SPMB Search, placing C-Suite and VP-level leadership into high growth venture and private equity backed technology companies. She helped open up SPMB's New York office, growing its internal recruiting team along with expanding the firm's talent network and clients on the east coast. In her earlier career, Carleigh worked at Hall Capital Partners in San Francisco, an investment advisory firm, managing and servicing portfolios for ultra high net worth individuals, foundations and endowment funds.Carleigh believes that building trust and fostering deep connections is a significant catalyst and signal of a company's future success.

Kelsey is part of the U.S. marketing and communications team, supporting content and media for Index and its portfolio companies.Before joining Index, Kelsey spent nine years at the integrated PR firm Inkhouse, where she led communications strategy for technology startups ranging from seed and Series A to publicly traded companies, driving holistic programs that included messaging development, media support, content, and events.Kelsey is a graduate of Gonzaga University with a B.A. in public relations. She loves exploring the SF Bay Area and spends her free time wine tasting, taking long walks in Golden Gate Park, and browsing her neighborhood library.

Martin backs early-stage founders building transformative products in healthcare, AI, and financial services. He was one of the earliest investors in Revolut, partnering closely with the team from day one to help scale one of the world's most iconic fintech platforms.Since joining Index in 2010, Martin has led early investments in breakout companies, including Algolia, Swile, Trainline, Deliveroo, Nourish, and Personio – all now valued at over $1 billion. In 2022, he helped establish Index’s New York office, expanding the firm’s U.S. presence and partnering with globally minded founders, whether they start in Europe or North America.Martin is particularly drawn to products that leverage AI and automation to improve with each user, driving down costs, expanding access, and fundamentally reshaping industries. His track record has earned him multiple appearances on the Forbes Midas List, which recognizes the world’s top tech venture capitalists.Outside of venture, Martin is passionate about urban design and the future of cities. He’s the founder of Happy Streets, a foundation advocating for safer, more walkable, and less car-dependent neighborhoods.

Hunter is a Partner at Index Ventures, where he invests across verticals and at every stage of growth. He looks for relentless founders taking on hard, consequential problems, and enduring companies built with real craftsmanship and care. Above all, he optimizes for slope over intercept -- less concerned with where a founder begins than with how fast they climb.Before joining Index, Hunter was a General Partner at 9Yards, where he served on the board or worked with companies that include Toast, Gusto, Wonderful, Capital Rx, Remote and Capitolis. Prior to 9Yards, Hunter worked in venture at Willoughby Capital and private equity at Gamut Capital. Hunter started his career in Tech M&A at JPMorgan.Hunter graduated with honors from the Wharton School at the University of Pennsylvania. Hunter grew up in Vancouver, Canada.

Avron oversees the development of internal products and systems for the investment teams in London, San Francisco and New York. He also manages the firm’s IT infrastructure. Prior to Index, Avron served as Head of Product and COO, primarily at fintech startups. Avron graduated from the University of Cape Town with a Business Science degree majoring in finance and economics.

Adrianna is the operating partner of Index. She is responsible for the operations of Index, including people/HR, finance, IT, investor relations, legal & compliance. She also facilitates the investment process and is responsible for fundraising and capital partnering.Prior to joining, Adrianna was a managing partner of the investment firm Fremont Group, a managing director of General Atlantic and a Tech M&A banker at Morgan Stanley.At Fremont Group, she oversaw a portfolio of actively managed funds, public securities and private co-investments, chaired the investment committee and assisted with Fremont’s direct private equity investments. During her ten years at General Atlantic, she led investments in, and served on the boards of, growth-stage technology companies around the world. At Morgan Stanley, Adrianna focused on technology-related mergers and acquisitions.Adrianna serves on the investment committees of the MIT Investment Management Company. She is also a term member of the MIT Corporation and a life member of the Council on Foreign Relations.Adrianna received a BS in electrical science and engineering, and an ME in electrical engineering and computer science from MIT. She also holds an MBA from Harvard Business School.

Vlad is a Venture Partner at Index Ventures, where he invests and supports founders across AI and consumer, including companies such as Kindred, BRINC drones, Daydream, and Anthropic. He currently serves as the Chief Creator Ecosystem Officer at Roblox, leading Creator Product, Developer Relations, and the Innovation Studio.Vlad is a product leader and technology entrepreneur with deep experience across the industry. Vlad spent the bulk of his career at Airbnb, where he was the first growth product manager, going on to partner closely with Brian Chesky to build the company, and finally serving as VP of Product and GM for the core hosting business. Prior to Airbnb, Vlad built games at Zynga, founded a social survey company, and worked in derivative trading at Morgan Stanley.Vlad graduated with an MBA from Harvard Business School and a BS in Business Administration and Economics from Carnegie Mellon University. In his free time, Vlad is an avid gamer, sci-fi enthusiast, and aspiring pianist. Vlad resides in San Francisco with his wife and has three startups of his own at home – two very passionate toddlers and a goofy labradoodle. His dream is to one day be selected for the reality show Survivor.

Jacob joined Index Ventures in 2015​, and ​is responsible for building Index's network of executives & entrepreneurs. Prior to joining the firm, Jacob worked in both the TMT ​Investment ​Banking​,​ and ​Engineering ​Divisions of Goldman Sachs. Jacob holds a B.A. in public policy from Vanderbilt University.

Stephane joined Index in 2020 as a venture partner after three decades as an operator in senior roles in European tech businesses. He focuses on supporting entrepreneurs with a strong belief in purpose-driven leadership.Prior to joining Index, Stephane was chief operating officer of King Digital Entertainment (KING), maker of Candy Crush Saga. He was part of the team that oversaw its $7B IPO – one of the largest for a European tech company at the time – and subsequent acquisition by Activision Blizzard. Prior to King, Stephane worked across almost every business function in a variety of European tech companies, including in sales, product, finance and senior management. He has also been a consultant at McKinsey & Co.Stephane has a BSc in Economics from the Université Libre de Bruxelles, a diploma in International Relations from the Johns Hopkins University School of Advanced International Studies with an MBA from Insead.

Rebecca is the Director of Investor Relations and has been with Index since 2021. She leads Index fundraising activities and ongoing engagement with Limited Partners. She is based in London, but like Index, has roots across the US, UK and Switzerland.Rebecca started her career at American Express, for 10 years working in a range of product, marketing and portfolio management roles. She holds a B.S. in Finance and Marketing from UPenn’s Wharton School of Business where she was part of and captained the UPenn Women’s Varsity Swim Team.

Bastian backs original thinkers who execute intensively and attract exceptional people — then follows them wherever their ambition leads, from horizontal AI platforms to software infrastructure, quantum, and space. He backs technical founders at every stage and pays more attention to the ambition behind a company than the category it falls into. His investments span Europe and the US, with a strong focus on the DACH market and the Nordics.Before Index, Bastian led Picus Capital's Berlin office, investing at pre-seed and seed. He holds an M.Sc. from ETH Zurich and a B.Sc. from KIT.

With a focus on data and financial services, Jan has a track-record of spotting young companies that will go on to reshape the workings of the digital economy at its very deepest level. Jan was an early-stage investor in Adyen, which IPO'd in 2018 and in Robinhood and Wise which both floated in 2021. Other companies in his portfolio include Alan, Collibra, Capitolis, and SafetyCulture. Jan joined Index in 2010, after working as an investor at General Atlantic and an investment banker at Morgan Stanley. His career in finance offered him insight into the extraordinary opportunities available to founders who are audacious and determined enough to rebuild the structures that govern fundamental flows of data and information. His approach as an investor is characterised by his desire to build long-lasting personal relationships and a deep conviction in his founders and their visions.Jan holds an MBA with Distinction from INSEAD, and is a graduate of Oxford University. Beyond venture, Jan works with the TATE in London to develop its Central and Eastern European art collection.

Myles is Senior Legal Counsel in Index's San Francisco office, supporting Index's investment team on all phases of negotiation and execution of investments and divestments of portfolio companies, and ongoing general corporate portfolio counseling.Prior to joining Index, Myles was a Senior Associate in Fenwick & West LLP's San Francisco office, where he advised venture capital funds and corporate venture capital groups in their investments and ongoing portfolio matters, as well as emerging and growth stage technology and life sciences companies, from formation through exit. Myles is admitted to practice law in California. He received his JD from the University of California College of the Law, San Francisco, and a B.A. degree from the University of Southern California. Outside of work, Myles is an avid skiier and runner.

Carlos joined Index as a partner in January 2021 to focus on SaaS, Open Source, Security, Financial Services, AI and Infrastructure/DevOps. Most recently, Carlos was the COO, and before that CPO and CTO, of UK-based fintech, GoCardless. Before that, he was Skyscanner's Chief Product Officer following the acquisition of Fogg, a travel startup he founded. He is an angel investor in more than 60 companies including Codat, cargo.one, Hopin and Shapr3D, and serves as a board director at GoCardless.

Nina Gerson is a Partner at Index Ventures in San Francisco where she invests in founders solving highly technical problems across AI, infrastructure and security. Having invested from the earliest bets through a company's journey to IPO, she looks for founders who pair the ambition to build a generational company with the relentless blocking-and-tackling of everyday startup life.Before joining Index, Nina was a General Partner at Coatue, serving on the board or working with companies including Databricks, Decagon, Rippling, Cyera, Island, and Legion Security. Prior to Coatue, Nina was an investor at CapitalG, Google’s investment arm. Nina started her career as an investment banker with Union Square Advisors.Nina graduated from Washington University in St. Louis, where she was a goalkeeper on the NCAA championship-winning soccer team.

Dan is a Venture Partner at Index Ventures, where he invests and supports B2B software and AI companies.He is inspired and energized by working with founders, and aims to inspire and energize them in return. He is particularly talented at helping founders with recruiting and go-to-market strategy, facilitating collaboration across business units, aligning the C-suite, and proactively ensuring that promising companies get IPO-ready early on.Prior to joining Index, Dan served as Chief Revenue Officer at Datadog. He has worked at five startups, four of which had billion-dollar IPOs. He also serves on the board of Homes For Our Troops and founded Imagine Reading, which helps dyslexic students learn to read. Outside of Dan’s work and philanthropy, he continues to learn and challenge himself every day. He is an avid snowboarder and martial artist, and lives in Larchmont, NY with his wife and three kids.

Ali is the VP of People at Index. She leads Index’s internal talent function, providing strategic direction and overseeing the full scope of people operations.Ali is a talent management and leadership development executive with over 15 years of experience building teams and advising organizations across many industries and stages of growth. Most recently, Ali was the Chief Talent Officer at Nova Pioneer, a venture-backed leading education company in Africa. In addition to creating people operations infrastructure and systems, she brings with her a passion for fostering intentional workplace culture where people experience excellence, growth and joy. She began her career on the investment team at Wellington Management and also has experience in the African venture capital market at Knife Capital. Ali received her MBA from Stanford Graduate School of Business and a BA from Brown University. Outside of work, Ali is passionate about travel, education equity and wildlife conservation and enjoys sharing those interests with her children.

Michelle joined Index in 2020 and is the General Counsel. She advises entrepreneurs and investors on legal matters across all stages of a company's lifecycle. She assists Index's investment team with the negotiation and execution of investments, divestments, and general corporate matters. Michelle also handles US regulatory and compliance matters.Prior to Index, Michelle was a senior associate at Gunderson Dettmer in San Francisco, where she advised leading venture-backed private companies across stages and industries on financings, mergers and acquisitions, initial public offerings, and general corporate governance matters, as well as venture capital firms on corporate transactions. Michelle began her legal career as an associate focused on mergers and acquisitions at Wilson Sonsini in New York and San Francisco.Michelle is admitted to practice law in California and New York. She received a B.S. degree from Cornell University and her JD from Fordham University School of Law. Outside of work, Michelle is an avid foodie and enjoys biking, skiing, and traveling.

Katy partners with founders and operators on Operations and G&A hiring strategy, and works to build and deepen Index's executive and advisor network across the US.Katy has spent her career partnering with startup founders to build and scale their teams. Prior to Index, she spent five years leading talent at Gradient Ventures, an AI seed fund backed by Google, where she helped founders establish their early hiring processes and make critical leadership hires across their organizations. She also previously spent seven years in executive search, helping high-growth technology companies build their leadership teams.Katy believes that building a great team starts with deeply understanding what a company needs at each stage and she brings an enduring curiosity about people and organizations to help founders make those decisions.Katy graduated from the University of California, Berkeley with a degree in Anthropology and Education and currently lives in Oakland with her family. Outside of work she spends her time hiking in the Oakland hills, gardening, and exploring new cities and national parks.

Juriaan is based in Tel Aviv, investing across all stages from seed to growth. He was previously with Team8 and Liberty Technology Ventures working with founders of cybersecurity, fintech and enterprise infrastructure companies. Before that, Juriaan spent two and a half years in the Finance Department of the Israel Defense Forces (IDF), and founded a business consultancy for startups. He has a B.A. in Business Administration and Finance from the Reichman University in Israel.Juriaan speaks five languages, is an Ironman triathlete and a passionate gamer. He was born in the Netherlands, grew up in Spain and has spent the last 12 years living in Israel.

André joined Index in 2006 as General Counsel. He has over 20 years of experience advising entrepreneurs and investors throughout Europe and in the US on legal matters arising during all stages of a company's lifecycle. At Index, André assists the investment team on the negotiation and execution of investments, divestments and general corporate matters.Prior to joining Index, André started his legal career with Warner Cranston (now part of Reed Smith) in London, followed by his tenure within the transatlantic operations of Brobeck Hale and Dorr (now part of WilmerHale), where he focused on tech investments and mergers and acquisitions. André is a member of the Law Society of England and Wales. He received a Bachelor of Laws (LLB) degree from University College London and subsequently completed his legal training at the College of Law in London.

Sofia is an early-stage and growth investor at Index Ventures based in San Francisco, where she backs founders building category-defining companies in SaaS, AI, financial services, and gaming.Since joining Index in 2018, Sofia has led investments across Europe and the US. She serves on the boards or works with companies including Decagon, Dream Games, RevenueCat, Cradle, Atlar, Printify, and others.A former soccer player, Sofia is naturally drawn to founders with an athlete’s mindset—focused, resilient, and goal-oriented. Having grown up across Europe and now based in the US, she also believes that great companies can be built anywhere.Sofia was named to Forbes' Midas Brink List in 2025, which spotlights rising stars in venture capital. Prior to Index, she was an investor at EQT Ventures in Stockholm. She holds an M.Sc. from the London School of Economics.

Oxford Finance LLC is a US specialty finance firm headquartered in Alexandria, Virginia. It provides senior secured debt to life sciences, healthcare, health technology, SaaS and other software and technology businesses, alongside leveraged lending and healthcare real estate and asset-based financing. Its enterprise team supports product development, commercial growth, acquisitions and refinancing through term loans, delayed-draw facilities and revolving credit. Its neuroscience-related lending includes Monteris Medical and Neuronetics. Timothy A. Lex is President and Chief Executive Officer; founder J. Alden Philbrick IV is Executive Chairman. The firm and Oxford Finance Advisors LLC manage related credit vehicles, including Oxford Finance Credit Fund II LP, III LP and IV LP. Disclosed facility commitments and cumulative loan originations are not recorded as fund closing sizes or amounts actually drawn.

Eryk is a Partner at Index Ventures, investing across all stages in enterprise software, infrastructure, robotics, and AI. Eryk is drawn to ambitious founders with deep domain expertise and unwavering customer obsession.Prior to Index, Eryk served as Chief of Staff to Ali Ghodsi at Databricks. During his tenure, Eryk had a front-row seat to one of the fastest-growing enterprise software companies in history, working across every aspect of the business – from product and engineering to sales and operations. Eryk started his career at The Boston Consulting Group, where he focused on enterprise software. He holds a B.A. in Applied Math and Economics from Harvard University.Based in San Francisco, Eryk is an avid weightlifter, ski enthusiast, and voracious reader.

Simon is the Chief Financial and Administrative Officer at Index. He has over 20 years experience in financial services, spanning private and public markets, wealth management and banking. Prior to Index, Simon was the Group Finance Director and Director of Corporate Development of Federated Hermes, a global investment firm, where he was a member of the senior management committee and had responsibility for finance, tax and corporate development.Prior to Federated Hermes, he worked for Kleinwort Benson, TMF and KPMG.Simon is a fellow of the Institute of Chartered Accountants in England and Wales and graduated from University College London.

Thea (Theodora) is Index’s Senior Legal Counsel focusing on the structuring, formation and ongoing operation of Index’s funds as well as advising the investor relations team. She joined the team in 2023.She was attracted to venture capital due to its inherent long-term and collaborative nature, at both fund and portfolio company level. “Fundraising negotiations are very different to almost anything else in finance and corporate law”, explains Thea. “Whereas so much of a lawyer’s role can be adversarial, raising a venture capital fund is about forming a close partnership with your limited partners based on mutual respect.”Prior to joining Index, Thea was a senior associate at Latham & Watkins in London, where she represented and advised alternative investment funds, institutional investors and global asset managers. She studied history at the University of Durham and has completed the Investment Management Certificate (CFA UK). Since 2020, she has been trustee director at Essex Blind Charity.

Brendan has been at Index since 2006 when he joined to open the Jersey office. He oversees the financial aspects of the fund structures and other Jersey registered entities. Prior to Index he was a senior manager within the audit department of KPMG in Guernsey with a focus on financial services clients. Brendan started his career with Johnston Carmichael in Scotland, qualifying as a Chartered Accountant (ICAS) in 2000. He holds an honours degree in Mathematics, Statistics and Accounting from the University of Strathclyde.

Sujata Bhatia is an Executive in Residence at Index Ventures, where she supports founders as they scale their companies and leadership teams.During her five years as COO of Monzo, she helped turn around the business and then led it through rapid growth and profitability. In addition to scaling the company’s operating model, her remit spanned growth, operations, marketing, design, brand, people, and risk. Before Monzo, Sujata spent 15 years at American Express in senior global roles across consumer and B2B businesses, holding both general management and functional leadership roles across payments, product, rewards, marketing, and partnerships.Sujata enjoys working with ambitious founders on the challenges that emerge as companies scale: building leadership teams, evolving structures, sharpening operating rhythms, and delivering standout customer experiences alongside commercial performance. Across fintech and consumer and small business platforms, she has particular experience in building distinctive brands and driving rapid growth in complex, regulated environments.Outside of work, she loves theatre, travel, watching her favourite Boston sports teams, and spending time with her husband and two daughters.

Kelly is an early-stage and growth investor at Index Ventures, where she partners with founders building category-defining companies. She is drawn to founders that are relentlessly curious, deeply resilient, and have found a problem that uniquely fits their strengths.Before joining Index, Kelly invested at CapitalG, backing companies like Stripe, Base Power, Monzo, and Farther. Earlier in her career, she worked as a consultant at the Boston Consulting Group. She holds a B.S. in Mathematics from MIT.Kelly is based in San Francisco and in her spare time races triathlon professionally in long-distance races, spends time on the water, and is attempting to pick up tennis.

Isaiah advises and supports Index portfolio companies on talent management. He works closely with leadership teams to define and establish their compensation approach and broader talent strategies. An experienced talent and rewards leader, Isaiah has held key roles at scaling organizations across the US and Europe, most recently at Checkout.com and WeWork. At Checkout.com, he helped to develop a high-performance focussed culture by building out the company’s global compensation strategy, ESOP, diversity and inclusion initiatives, people analytics and global mobility programs. At WeWork, he hired the first rewards team while scaling the business from 2,500 to 15,000 employees, before managing complex equity challenges through restructuring and a SPAC transaction. Isaiah believes in the power of compensation to drive results and works with founders on harnessing this to aid company growth.

Sahir Azam is an early-stage and growth investor at Index Ventures. Based in New York City (and traveling regularly to San Francisco and London), he partners with founders building category-defining companies in AI, data, infrastructure, and security.Over his career, Sahir has built a unique operating career at the intersection of business and technology. He initially discovered his passion for go-to-market at BladeLogic/BMC, moved into product leadership at VMware and SumoLogic, and spent nearly a decade at MongoDB, where as Chief Product Officer he helped scale it into one of New York’s defining tech companies.A former ice hockey goalie (yes, really) and lifelong technology enthusiast, Sahir embraces many passions outside of work. In his free time, he loves to snowboard, enjoy wine, and travel the world.

Ana leads marketing and communications in the U.S., where she enjoys working with founders and entrepreneurs at portfolio companies on their comms goals and challenges. Prior to Index, Ana was Head of Comms at Dropbox for nearly four years, during which time the company scaled from 400 to 2,000 people. While there, she built and managed the first global comms team, leading a wide range of activities from corporate events to product launches to managing crises and various policy issues.Previously, Ana managed communications at Jive Software and HP Software and held senior roles at Outcast and Hill and Knowlton. Ana holds a B.S. in humanities in world affairs and a certificate in Latin American studies from Georgetown University. Originally from Romania, Ana has lived in four different capitals of the world and currently lives in San Francisco with her husband and daughter.

Julia joined Index in 2019 to focus on B2B Saas and Fintech across Europe. She is especially interested in businesses that increase transaction efficiency and enable retail and business commerce to shift digitally. Prior to joining Index, Julia worked at Palantir, where she led commercial deployments and analytics for enterprise customers in multiple industries including Banks, Oil & Gas, Financial Services, and Supply Chain. Julia holds an MS in Engineering from Stanford University, where she led two years of mathematical research in Anomaly Detection, and an MS in Engineering from Ecole Nationale des Ponts et Chaussées.

Nina is a partner at Index Ventures, investing across seed, venture, and growth stages in AI, robotics, software for hardware, and vertical SaaS. She is excited by companies that build solutions to automate “forgotten” functions and industries, replacing pen and paper and siloed tools. Nina is inspired by founders who develop empathy for their customers, have an insatiable curiosity, and operate with a growth mindset.Nina currently serves on the boards of or works with companies including ServiceTitan, Physical Intelligence, Anthropic, Quilter, Gong, Vizcom, and Transcend, among others.Prior to Index, Nina worked at Google as an FP&A Lead, where she helped build the GTM infrastructure of the AdSense sales organization. She started her career as a bond trader in New York and London and founded HIVE Ventures, the first seed fund focused on Armenian entrepreneurs.Nina was featured on Forbes' Midas Brink List in 2022, which recognizes up-and-coming leading investors. She graduated from Harvard University with a B.A. in government and is a recipient of the Michael C. Rockefeller Scholarship. Nina currently lives in San Francisco and, in her spare time, can be found watching football and Formula 1.

Venture partner at Lorimer Ventures. The firm’s public directory describes Malcolm Kerr as Director, Business Operations and Strategy at Formic. This outside position is attributed to the firm directory; no separate employer role is created.

Venture partner at Lorimer Ventures. The firm’s public directory describes Pooja Mehta as Member of Product Staff OpenAI. This outside position is attributed to the firm directory; no separate employer role is created.

Venture partner at Lorimer Ventures. The firm’s public directory describes Will Lyon as Head of Channel Marketing at Rippling. This outside position is attributed to the firm directory; no separate employer role is created.

Venture partner at Lorimer Ventures. The firm’s public directory describes Jake Gertjan Hofwegen as VP, Revenue Ops + Enablement at Contentful. This outside position is attributed to the firm directory; no separate employer role is created.

Venture partner at Lorimer Ventures. The firm’s public directory describes Wesley Barrow as Partner at Correlation Ventures. This outside position is attributed to the firm directory; no separate employer role is created.

Venture partner at Lorimer Ventures. The firm’s public directory describes Vlad Pick as Cofounder and CTO at Tone (acquired by Attentive). This outside position is attributed to the firm directory; no separate employer role is created.

Venture partner at Lorimer Ventures. The firm’s public directory describes Alex de Ráfols as Director, PM at Affirm. This outside position is attributed to the firm directory; no separate employer role is created.

Venture partner at Lorimer Ventures. The firm’s public directory describes Alfonso Marqués as Founding Engineer at Polar Signals. This outside position is attributed to the firm directory; no separate employer role is created.

Venture partner at Lorimer Ventures. The firm’s public directory describes Ishita Aloni as Engineering Manager at Loop. This outside position is attributed to the firm directory; no separate employer role is created.

Venture partner at Lorimer Ventures. The firm’s public directory describes Phil Gurbacki as VP, Product at Weights & Biases (Coreweave). This outside position is attributed to the firm directory; no separate employer role is created.

Zach has spent the last 10 years working in Product Management, UX, and Growth roles in the New York tech ecosystem. He is currently a Lead Product Manager at Attentive building messaging products. Before Attentive, Zach was a Product Manager at Yext (NYSE: YEXT), developing its Knowledge Graph product and working closely with Stephan. Previous to Yext, Zach worked on the Financial Products UX team at Bloomberg LP building cross-asset trading functionality on The Terminal for both Buy-Side and Sell-Side clients. Zach holds a BA from Cornell University in Government and lives in Manhattan.

Pete has spent 15+ years advising global industrial companies and investing in early-stage businesses. He joined Broadscale in 2014 as its first hired investment professional, building a $150M deal-by-deal venture platform from scratch. Pete was among the earliest venture investors to recognize the opportunity in smart, connected, and distributed energy resources. During his tenure, Broadscale became the largest and earliest investor in Audigent (acquired by Experian) and took two companies public on the NYSE. Pete holds a BA in Public Policy from Duke University and lives in Brooklyn.

Nick has been an investor and lender his entire adult life. He began angel investing in 2017 and has over 45 direct investments and 2 exits. In addition to running Lorimer Ventures full-time, Nick is also a Venture Partner with LaunchTN, and AgLaunch365. Prior to Lorimer Ventures, Nick spent 10 years as a senior banker within the Farm Credit system, most recently as Vice President, Food & Agribusiness where he oversaw the sourcing, structuring and syndication of large corporate credits. Prior to Farm Credit, Nick was an equity derivatives trader and in structured credit sales at Citigroup (NYSE: C). Nick holds dual degrees in History and Economics from Colby College and splits his time between Nashville and New York City.

Borusan Ventures is the standalone corporate venture capital arm of Borusan Group, established in 2023 and based in the San Francisco Bay Area. It invests in early-stage businesses, especially in the US and Europe, across mobility, logistics, industrial technology, supply chains, energy and climate. Its published portfolio includes AI agents and industrial decision systems, automotive remote diagnostics, AI compliance for nuclear operations, energy storage optimization, hydrogen electrolyzers, machinery monitoring, and recycling and critical mineral services. Founder and Chair Defne Kocabiyik Narter and Managing Partner Timo Kilp lead investment activities, supported by associates, venture-development specialists and separately named advisers and investment committee members. Corporate operating knowledge and commercial partnerships complement financing. Borusan’s parent reports five venture fund commitments and five direct startup investments completed in 2024; these are outgoing investments, not externally raised Borusan venture fund corpus. A separately verified LP fund closing amount and date are not established. The corporate venture arm is kept distinct from the broader group’s operating companies and their industrial capital expenditure.

David Singer has served on Infleqtion’s board since April2024. He leads Maverick’s private investments, which he joined in2004, and is Managing Partner of Maverick Ventures. He previously founded and led Affymetrix, Corcept Therapeutics and Genesoft Pharmaceuticals. He holds degrees from Yale and Stanford.

Marcus Kupferschmidt is Head of Investor Relations and Strategic Finance at Infleqtion. The company identifies him as its public investor contact. His company-published introduction describes more than twenty years in technology investing, investor relations and finance, including prior leadership roles at Hewlett Packard Enterprise.

Dawn Meyerriecks has served on Infleqtion’s board since May2022. She is a technology and national-security leader whose prior roles include leading CIA science and technology, intelligence-community technical oversight and AOL product transformation. She is also a commissioner on the National Security Commission on Emerging Biotechnology.

Kristina M. Johnson has served on Infleqtion’s board since June2024. An engineer and entrepreneur, she has led universities, founded hydropower businesses and served as US Under Secretary of Energy. She currently works in energy and industrial technology investment through Catalyzer and Johnson Energy Holdings. Her academic and public-service leadership appointments are historical.

Nicholas Johnson joined Infleqtion’s board on May14,2026. He is a Managing Director at M. Klein & Company and Partner at Archimedes Advisor Group, where he leads Churchill Capital franchise investments including Infleqtion and Oklo. He previously worked in investment banking at Morgan Stanley and holds a business administration degree from Babson College.

Eric Bjornholt is an Infleqtion director, serving since December2025. He is Senior Corporate Vice President and Chief Financial Officer at Microchip Technology, which he joined in1995; he became CFO in2009. His background includes corporate finance, financial reporting and taxation.

Catherine Lego chairs Infleqtion’s board, which she joined in December2023. She is an experienced technology director and financial adviser, with current board service at Guidewire and Cirrus Logic. She previously led Lego Ventures from1992 to2018 and served on semiconductor and photonics company boards.

Alain Aspect is a physicist and2022NobelPrize laureate whom Quantonation identifies as its scientific advisor. His research includes quantum entanglement and atom optics; he supervised co-founder Christophe Jurczak doctorate. Advisory role doesnot establish personalcashinvestment in every portfolio company.

Charles Beigbeder launched Quantonation in2018 alongside Christophe Jurczak and Olivier Tonneau, backed by his Gravitation holding company and initially managed through Audacia. He founded Audacia and is an entrepreneur with experience founding Self Trade and Poweo. Co-founder is a historical enduring attribution, not an inferred current daily executive title.

Eléonore de Rose was named Quantonation Director of Communications and PR in its own November2025 announcement and an operator supporting FundII in February2026. She is absent from the current eight-person directory; her current Exergon biography lists Communication. No unverified end date or current investment partner title is inferred.

Marie-Sophie spent seven years as a Venture Capital and M&A lawyer at Gide Loyrette Nouel, focusing on tech transactions. She advised both startups and VC funds across the full lifecycle – from seed financing through exit – and completed a one-year secondment to the firm’s New York office. She was admitted to the Paris Bar in 2018 and holds a Master’s degree (M2) in Business Law and Taxation from Panthéon-Assas University, along with a Certificate in Banking and Financial Law.

Will Zeng joined Quantonation as Partner in July2023 and was named a FundII partner in February2026. His current own website explicitly describes the Quantonation partnership as previous work; he now leads the Unitary Foundation open-source quantum technology lab. He formerly led quantum research at Goldman Sachs and helped build Rigetti computing cloud products, and holds an Oxford doctorate and Yale physics degree.

With several experience in the finance and strategy, Yu-Hsin brings a wealth of knowledge and expertise to her new role. Prior to joining Quantonation, she graduated from ESSEC with extensive experience in Paris working for various companies. Last two were working for Devoteam and Danone HQ where she honed her expertise in financial planning and analysis, business partnering, and investment at global level.

Raphaël rejoined Quantonation as an Analyst and was later promoted to Associate. He graduated from ESCP Business School’s PGE program and also holds a bachelor’s degree in Mathematics. During his studies, he gained experience in private equity at Arkéa and venture capital at Quantonation. He further strengthened his organizational and operational expertise by serving as Chief of Staff to the COO at Qubit Pharmaceuticals for a year.

Returning to Quantonation as a Senior Analyst, YLan graduated from ESSEC Business School’s PGE program. Throughout her studies, she built extensive experience in the quantum ecosystem, completing internships in venture capital at Quantonation and in startups at Quandela and Alice&Bob. She also played an active role at Le Lab Quantique, accumulating three consecutive years of hands-on involvement in the Quantum Realm.

Joseph was called to the Bar of England & Wales in 2024 after completing the Bar Course at City Law School and a two-year GDL. He also holds various legal qualifications, including an International Trust Management Certificate from STEP and a Corporate Taxation Certificate from Francis Lefebvre. Joseph is Member of the board of Quantum Ventures Studio.

Emily is a Physicist by training holding a bachelor’s and two Masters degrees in Physics from the University of Bath and Politecnica Madrid. Understanding that key enabling technologies can sometimes get lost behind the walls of academia, she is excited the most by helping founders take their technology out of the lab and into the real world. Having spent several years investing in Deep Tech at Speedinvest, she believes technical leaps lead to the greatest disruption and innovation. In particular, Physics based technologies have always taken a special place in her heart and professional activities. Fiercely curious, Emily is always ready for her next challenges, and strives to encourage a founder-first attitude, and ensure scientific credibility is kept on the VC side of the table.

Dr. Jurczak has held government and executive positions in energy, defense and in the emerging field of quantum computing, in Europe and in the US, before co-founding Quantonation Ventures in 2018. He holds masters degree in Engineering and Quantum Physics respectively from Ecole Polytechnique and Ecole Normale Supérieure in Paris. He also holds a PhD in Quantum Physics under the supervision of Prof. Alain Aspect (Nobel prize 2022) on laser cooling of atoms. Christophe has been selected among the 20 Influential Individuals in Quantum Tech by Quantum Zeitgeist.

A graduate from ESSEC business school, Olivier is founder and partner at Quantonation. Previous experiences include 10 years as management consultant at Kearney, before joining French entrepreneur Charles Beigbeder as CEO at his holding company, Gravitation. Olivier is a board member at Multiverse Computing, Qnami, KETS Quantum Security, EvolutionQ, QC Design, Kipu Quantum, Cryptonext Security, Quobly and the Quantum Industry Consortium (QuiC). Olivier has recently been selected to be part of the class 28 of the Kauffman Fellows program, a prominent venture education program renowned for its extensive and well-established network of VCs.

Quantonation is an early-stage venture investment firm focused on quantum technologies and businesses built on advances in physics and computing. Founded in2018 by Christophe Jurczak, Olivier Tonneau and Charles Beigbeder, it invests globally from pre-seed through SeriesA and supports selected companies through SeriesB. Its portfolio spans quantum computing and networking, sensing, photonics, advanced materials, AI, cybersecurity, drug discovery and medical imaging. Its current public directory lists eight staff: Christophe Jurczak, Olivier Tonneau, Emily Meads, Joseph Maillard, Raphaël Bodin, Ylan Tran, Yu-Hsin Wang and Marie-Sophie Chevreteau. Nobel laureate Alain Aspect is a scientific advisor. Quantonation I closed at EUR91M in2022; Quantonation II announced its final EUR220M close onFebruary18,2026, above an earlierEUR200Mtarget. Quantonation Ventures is the legal French management company, SIREN849813522, AMFauthorizationGP-202211. The current team site locates the firm in Paris and Dallas; older releases reference Boston and NewYork. Will Zeng's current own website describes his Quantonation partnership as previous work, despite his appearance in earlierFundIIannouncements.

Oakland-based early-stage venture investor supporting founders developing digital technology for energy, utilities, mobility, industry and decarbonization. Founded by Emily Kirsch in 2018, the firm invests in software, artificial intelligence, grid analytics, industrial optimization and energy infrastructure. Its published portfolio includes Tyba, ThinkLabs AI, Overstory, CVector and Pearl Street Technologies. The current public directory names ten staff members, led by founder and Managing Partner Emily Kirsch and Partner Marie Thompson. Powerhouse Ventures operates alongside the separate Powerhouse Innovation consultancy. Its own Fund II announcement reports a USD75 million close; Fund I and Fund III records retain separately qualified SEC securities-sold disclosures. Fund III’s USD100 million offering target is not completed fundraising. The Climate display qualifier distinguishes this Oakland firm from the separate existing Powerhouse Ventures record with Indian consumer/internet portfolio links; that record and its financial relationships remain preserved.

Graduate Associate and MIT Sloan MBA student. Previously worked in Barclays investment banking on clean technology and automotive transactions and held an MBA fellowship at Clean Energy Ventures.

Founder and Managing Partner of Powerhouse Ventures, which she established in 2018. Previously worked on California clean-energy initiatives alongside Van Jones and hosts the Watt It Takes podcast.

Operations Associate joining in 2026, supporting reporting, analytics, deal pipelines and internal systems. Previously worked in operations at Amazon and an enterprise software company.

Principal involved in sourcing, diligence and portfolio support since joining in 2022. Previously advised utilities at E Source on demand management and electrification, and served in the Peace Corps in Costa Rica.

Principal supporting investment sourcing, diligence and portfolio companies since joining in 2022. Holds a University of Michigan JD/MBA and previously worked at Bosch, Orrick, ENGIE and Anthesis Group.

Executive Assistant supporting firm leadership since joining in 2026. Previously held executive and administrative support roles in real-estate management and heat-pump manufacturing.

Marketing and Communications Director, joining in 2026. Previously led marketing at WeaveGrid and worked at Energy Solutions.

Senior Associate supporting investment sourcing, diligence and fund operations since joining in 2025. Previously worked in economic consulting and held graduate investing positions at DBL Partners and Evergreen Climate Innovations.

Partner leading Powerhouse Ventures investment diligence and fund strategy. Joined in 2019 following work across energy strategy, planning, finance and risk.

Principal responsible for sourcing, diligence and portfolio support since joining in 2021. Previously worked at Trellis/GreenBiz and on nonprofit energy-efficiency and renewable-energy initiatives.

Co-author of Mistral’s September 2026 case study on modernizing legacy scientific code using AI agents.

Seoul National University professor specializing in energy economics and technology policy.

Hansung University Applied AI professor specializing in robotics and control systems.

Seoul National University semiconductor and AI chip researcher and professor.

Executive chairman of Samsung Electronics, also known as Lee Jae-yong. Distinct from the independent chairman of its board. Current title reaffirmed in Samsung’s October 1, 2026 newsroom announcement.

Economic policy and financial regulation specialist, former chairman of Korea’s Financial Services Commission.

Co-founder and former Chief Science Officer of Emmi AI. Mistral announced Emmi’s founders would join its Science and Applied AI teams in May 2026; September 2026 issuer news confirms the acquired team joined. This is not a Mistral Chief Science Officer appointment.

Rainbow Robotics founding member and KAIST honorary professor. Samsung’s December 31, 2024 announcement states he will lead its Future Robotics Office after retiring from Rainbow Robotics; independent later confirmation of continued tenure not recovered.

Chief investment officer of the National University of Singapore Endowment Fund, with previous investment leadership at GIC and Samsung Asset Management. Member of the Novo Holdings Board since 2025. Member of the Novo Holdings Remuneration & Nomination Committee. Jun Sung Kim was born in 1967 and is a Singaporean national. Jun Sung Kim brings more than 30 years of experience driving investment performance across direct public and private equity strategies, engaging stakeholders, and building and managing direct investment teams across Singapore, London, and New York on behalf of the GIC over 17 years. Prior to this he has worked at Warburg Pincus, Samsung Asset Management and WI Carr. Jun Sung is currently the CIO of the National University of Singapore’s endowment fund, investing across public and private strategies globally. He is a main board member of Samsung Electronics in Korea. His global perspective and track record in managing complex investment portfolios will be instrumental as Novo Holdings continues to grow its presence in Asia and beyond.   Other Board Positions and Management Duties:   Samsung Electronics: Chair of Sustainability Committee, member of Remuneration Committee, member of Nomination Committee. Advisor to the UWC Endowment Fund

Authored Mistral’s January 2026 engineering investigation into a vLLM memory leak.

Co-author of Mistral’s September 2026 case study on modernizing legacy scientific code using AI agents.

Smartphone engineering executive leading the company’s consumer device and mobile businesses; also known as TM Roh.

Oversees semiconductor strategy, capital investment planning and operating efficiency.

Semiconductor executive and former Samsung SDI CEO, responsible for Samsung Electronics’ semiconductor division.

Appointed Wireframe Ventures Director of Platform in September 2022, supporting founder community, content, programs and internal operations. Her own joining article describes prior partnership and founder-support work at digitalundivided and Ladies Get Paid. She is not listed in the current published investment team; continuing appointment and departure date are unverified.

Partner of Wireframe Ventures, promoted in November 2024 after joining as a Principal in 2021. She invests in pre-seed and seed businesses improving healthcare and decarbonizing the economy. Previously an investor at Collaborative Fund, she has led new Wireframe investments and supported existing founders across climate, bioscience and health.

Co-founder and Managing Director of Wireframe Ventures, founded in 2016 around climate and human health. His own professional profile describes earlier investment roles at In-Q-Tel and RRE Ventures, leadership at Bina Technologies, and co-founding Orbit Commerce. Earlier personal or prior-firm investments are distinct from Wireframe’s post-2016 fund activity.

Co-founder and Managing Director of Wireframe Ventures, founded in 2016 to invest in climate, bioscience and health. He supports seed and pre-seed founders using software, data science and advanced physical technologies. A Duke Fuqua MBA alumnus, he previously worked with Claremont Creek Ventures; that prior firm’s investments are not automatically attributed to Wireframe.

Brent Schwarz is SVP Sales at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Evan Salim is VP Engineering Operations at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Grisha Spektor is VP Integrated Photonics at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Mark Saffman is Chief Scientist for Quantum Information at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Max Perez is VP & GM, Clocks at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Pritesh Solanki is VP Clocks & Products at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Troy Smith is General Counsel at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Chris O’Brien is Managing Director, Australia at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Dave Kresse is VP Commercial Solutions at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Lisa Pendergast is VP Proposals & Contracts at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Noah Fitch is VP Emerging Technologies at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Caitlin Carnahan is VP Quantum Software at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Chris Cook is VP Government Affairs at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Fred Chong is Chief Scientist of Quantum Software at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

William Clark is VP Business Development at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Colin Sullivan is Managing Director, UK at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Joseph Buck is SVP Quantum Computing Systems at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Ilan Hart is Chief Financial Officer at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Jason Hall is Chief Legal Officer at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Julie McGee is Chief Administrative Officer at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Karl Pendergast is SVP & General Manager, Quantum Sensing Solutions at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Paul Lipman is Chief Revenue Officer at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Ryan Hanley is Chief Technical Officer, UK at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Dana Anderson is Chief Science Officer & Founder at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Matthew (Matt) Kinsella is Chief Executive Officer of Infleqtion and a board director. He became CEO in April2024 after joining the board in July2018 as a founding investor. He previously served as a Managing Director at Maverick, where he worked from2005 until April2024, focusing on software and private technology investments.

Patricia Elias is Chief People Officer at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

Pranav Gokhale is Chief Technology Officer & General Manager, Quantum Computing at Infleqtion, the publicly listed neutral-atom quantum computing, sensing and software company. The company identifies this current role in its public leadership directory.

James (Jim) Murphy is Invenergy’s co-founder and chief executive officer and a member of Energize Capital’s investment committee. This energy-industry executive is distinct from the existing Forum Ventures person named James Murphy.

Emily Fleming is an associate on Energize Capital’s EDGE portfolio-services team, supporting commercialization and value creation. She earned an MBA at the University of Chicago Booth School of Business and previously worked with LVMH’s media and data team during her studies.

Iliana Griva is an associate on Energize Capital’s Ventures investment team. She supports sourcing, diligence and investment research across energy and industrial technology. She earned an MBA at UC Berkeley’s Haas School of Business.

Michael Polsky founded Invenergy and serves as its executive chairman. He chairs Energize Capital’s investment committee. His committee role is distinct from an Energize operating-partner appointment.

Tom Lei leads portfolio finance and operations at Energize Capital. Through Energize EDGE, he helps companies with financial planning, accounting strategy, transactions and finance-team development.

Sam Austin is an Energize Capital principal on the Endurance team. He develops investment theses, evaluates opportunities and works on portfolio management and value creation. He previously spent five years at True Wind Capital.

Aaron Donenberg supports Energize Capital’s EDGE portfolio-finance team through data analysis and financial reporting. The current team directory labels him portfolio finance associate; his biography uses portfolio finance analyst, so those published titles are qualified rather than assigned a promotion date.

Becks Bondi directs operations at Energize Capital. Working with the chief operating officer, she manages firm processes, talent systems and strategic operating initiatives. She previously held leadership responsibilities at General Assembly.

Kelsey Bolander is Energize Capital’s business operations and partner-support associate. She supports partners, coordinates team communication and manages office operations at the Chicago headquarters.

Grace Murphy is an Energize Capital impact and ESG associate. She supports the firm and its portfolio companies with sustainability strategy, measurement and reporting. She previously consulted at Bridge House Advisors.

Elisabeth Spencer is an associate on Energize Capital’s Endurance team. She evaluates investments through market research, financial modeling and diligence. She previously worked in investment banking at Nomura.

Michael Zuffante is Energize Capital’s accounting and finance associate. He supports management-company and fund reporting, valuations and investor reporting. He previously audited financial-services organizations at Ernst & Young.

Anson MacKinney is a senior associate on Energize Capital’s Ventures team. He develops investment theses and conducts market and financial diligence. He previously invested at Initialized Capital.

Agustina Soriano Sergi is a senior associate on Energize Capital’s Ventures team. She sources opportunities and conducts market research, competitive analysis and financial modeling to support investment decisions.

Robiny Jamerson is Energize Capital’s senior marketing and communications manager. She manages firm communications and helps portfolio companies with public relations, brand positioning and content.

Chloe Bierut manages community and events at Energize Capital. She organizes firm and portfolio programs and works with the EDGE portfolio-services team across its operating-support activities.

Suzanne Skibicki is Energize Capital’s senior accounting and finance associate. She supports fund and management-company reporting, valuations and investor reporting. She previously audited financial-services organizations at Ernst & Young.

Meredith Breach Bos is an Energize Capital principal on the Endurance team. She researches investment opportunities, performs financial and market diligence, and supports portfolio value creation.

Chris Bozzetti is Energize Capital’s controller. He manages management-company and fund accounting, financial reporting and budgets, and supports portfolio valuations and investor reporting.

Jeff Schmidt leads commercialization for Energize Capital. He helps portfolio companies develop pricing, sales, customer-success and business-development practices and connects them with commercial partners.

Eileen Waris is an Energize Capital Ventures principal. She sources and evaluates investments and helps portfolio companies commercialize their products, with a background in sustainability.

Mark Tomasovic is an Energize Capital principal on the Endurance team. He develops investment theses, sources opportunities and supports portfolio development. He began his career as a chemical engineer at ExxonMobil.

Alan Glass is an Energize Capital partner and co-head of Endurance, investing in profitable climate and industrial technology businesses. He previously spent seven and a half years investing at Vista Equity Partners.

Kevin Stevens is an Energize Capital partner and co-head of Endurance, its later-stage investment strategy. He previously founded Intelis Capital and has worked across energy-sector business development, product marketing and finance.

Lauren Densham is an Energize Capital partner leading portfolio services and impact. She directs Energize EDGE and supports portfolio value creation, responsible investment and impact measurement.

Juan Muldoon is an Energize Capital partner and co-head of Ventures. His responsibilities include investment research, sourcing, diligence and portfolio support. He previously worked at J.P. Morgan.

Katie McClain is an Energize Capital partner and chief operating officer. She directs firm operations and supports portfolio companies, diligence, investor relations and business development, drawing on energy-sector experience across public and private organizations.

Project assistant on the OSF Ventures team. She is publicly named with this role and a genuine portrait on the unit’s official current leadership directory. No undisclosed career or academic credentials are inferred.

Senior venture analyst at OSF Ventures, as identified in the current main directory. His longer biography describes financial modeling, business diligence, presentation of investment opportunities and venture reporting. He previously served as vice president of operations at a nonprofit providing pediatric physical and behavioral therapy and held financial executive roles at healthcare and insurance startups. He holds an MBA from the University of Louisiana Shreveport and business management and finance degrees from Olivet Nazarene University. The longer biography’s Venture Analyst title is older than the current main-page title.

Manager of venture investments at OSF Ventures, as identified in the current main directory. Her longer biography describes business diligence, financial modeling, investment-history tracking, portfolio revaluations and quarterly reporting. Before OSF, she held finance and business-operations roles in manufacturing and engineering. She holds accounting and management-information-systems degrees from the University of Iowa. The longer biography’s older Senior Venture Analyst title is retained as historical context, not the current title.

Director of venture investments at OSF Ventures, focused on medical devices and digital health. He previously led venture-capital work at Cardinal Health and worked in Cerner’s corporate venture team, supporting investments, partnerships, acquisitions and corporate strategy. He holds a business-management degree with a focus on entrepreneurship and innovation from the University of Nebraska-Lincoln.

Venture analyst at OSF Ventures. The current official leadership directory identifies him as Jeremy Snell, PhD, and publishes his genuine portrait. No unverified previous employers or specific degree institution are inferred.

Director of venture investments at OSF Ventures with experience across healthcare startups and corporate strategy. He previously worked as a healthcare strategy consultant and at Anthem on its IBM Watson partnership, followed by work with digital-health founders at Rock Health. He holds industrial engineering and economics degrees from Northwestern University and an MBA from the University of Virginia Darden School of Business.

Corporate venture investment unit of OSF HealthCare, operating within OSF Innovation in Peoria, Illinois. OSF Ventures invests in post-seed healthcare companies through investment syndicates and works with OSF clinicians and operating teams to test, refine and adopt technologies that may improve patient outcomes and patient experience or reduce the cost of care. Its focus includes health IT, medical devices, therapeutics, diagnostics and technology-enabled care delivery. Its AI and neuroscience portfolio includes autonomous diagnostic AI, wearable EEG and machine learning, bioelectronic medicine, migraine neuromodulation, AI-assisted clinical decisions and ultrasound imaging. The unit was founded in the last quarter of 2015 and began its first $75 million investment program in 2016. A second $75 million corporate fund launched in July 2019 and a third board-approved $100 million fund launched in January 2022, bringing the program’s reported capital under management to $250 million at that time. These are corporate capital allocations and fund launches, rather than asserted outside-LP fundraising closes. Its official portfolio separates direct companies, exited companies and investments as a limited partner in external healthcare funds. The current main-page team names seven people: vice president Mayank Taneja, directors Liridon Rrushaj and Ben Spektor, manager Danielle Kalinsky, senior venture analyst Samuel Martin, venture analyst Jeremy Snell and project assistant Elizabeth Eaker. The parent OSF HealthCare organization is preserved separately from this branded investment unit; the unit profile uses the authentic shared OSF HealthCare brand mark displayed on its own official page.

Austin Adams advises Variant on protocol mechanism design and early-stage technical development. He is building Whetstone Research and advises Uniswap Labs. His research covers blockchain markets, incentives and MEV, and he has contributed to Uniswap v4. Previously he researched at the Federal Reserve.

Salah Ghazzal advises Variant on blockchain policy and legislation. He previously managed policy and legislative analysis at the Blockchain Association, helping develop industry responses to market structure and stablecoin proposals. He has researched cybersecurity, emerging technology and conflict medicine and studied political science at the American University of Beirut.

Jake Chervinsky advises Variant on policy and regulatory strategy. He previously served as chief policy officer at the Blockchain Association and general counsel at Compound Labs. Earlier he worked on compliance and investigations at Baker McKenzie and crypto securities litigation and enforcement defense at Kobre & Kim.

Tara Kodosky is Variant’s office manager and operations analyst. Previously she worked in corporate services at Apollo Global Management and technical design at Almost Famous Clothing.

Justin Koonce is finance lead at Variant. The current official profile publishes his position and portrait but does not provide a detailed career biography.

Maria Falcone is an executive assistant at Variant with more than eight years of administrative experience. Before Variant she helped establish the administrative operations of her family’s business.

Tom Dils directs operations at Variant. Previously he was a senior investment associate at HarbourVest, covering venture managers and crypto-native funds while supporting its web3 initiatives. The current publisher biography contains a malformed education sentence, so no degree is inferred.

Chase Almen is Variant’s CFO, overseeing finance, treasury, valuation and institutional operations including tax, audit and fund administration. He previously led finance at a real-estate private equity manager and accounting at private-equity-backed businesses, beginning at KPMG. He is a CFA charterholder and CPA, with degrees from the University of Oklahoma and Wheaton College.

Caleb Shough is chief operating officer at Variant. The current official profile does not publish a career biography. His own published Variant writing includes decentralized AI artist Botto, hybrid ownership and crypto-native consumer applications.

Sabina Beleuz serves as deputy general counsel and investor at Variant, advising on fund legal matters, regulation and product structuring. Previously she practiced corporate governance and mergers law at Wachtell Lipton. She holds a Stanford JD and symbolic-systems degree and a Vienna LLM. Her research has covered blockchain law, game theory, GDPR and crypto transfer regulation; she previously advised Bain Capital Crypto as a researcher.

Caleb Shack is a Variant investment partner with previous infrastructure and cryptography investing experience at Big Brain Holdings. He studied economics, computer science and mathematics at the University of Pennsylvania, cofounded FranklinDAO and helped organize the Penn Blockchain Conference.

Elijah Fox is a Variant investment partner focused on technically ambitious early-stage projects. He founded exchange Duality, which was acquired, and researched auction theory and distributed systems. He studied computation and cognition at the University of Michigan, with an interest in AI and cognitive science.

Alana Levin invests in infrastructure at Variant, including token incentives, governance, scaling and privacy. She studied finance and public policy at Wharton, worked at the SEC during a summer placement and previously consulted at BCG. She publishes research through Back-of-the-Envelope and Mirror.

Daniel Barabander is an investment partner and chief legal officer at Variant. He combines software engineering and YC-backed startup experience with cryptocurrency law. Previously he advised institutions, DeFi projects and stablecoin issuers at Cravath. He began in product management at the New York Stock Exchange before founding a restaurant-ordering technology business.

Mr. Small joined the Investment Manager in February 2014 as Chief Operating Officer. From September 2002 to October 2013, Mr. Small worked at FBR & Co, an investment bank based in Arlington, VA. Mr. Small was a member of FBR's Operating Committee, a Partner at the firm and led FBR's Boston office as Managing Director of Institutional Equity Sales. From March 2001 to May 2002, Mr. Small worked in sales for EMC in both San Francisco and San Diego. From July 1999 to December 2000, Mr. Small worked in sales for North Systems, an internet startup company in San Francisco. Mr. Small holds a Bachelors of Arts Degree in History and German with a minor in Economics from Bowdoin College. Mr. Small is on the board of The Play Ball Foundation, which creates team sports opportunities for underserved middle school age youth in Massachusetts.

Mr. Trottier is currently the Chief Financial and Compliance Officer of the Investment Manager. Mr. Trottier is a Certified Public Accountant and holds his Series 6 and Series 7 Certifications. From 2021 to 2022, Mr. Trottier was an accountant for the University of Vermont Medical Center. From 2018 to 2020 he was a financial planner for Hickok and Boardman Capital Management. From 2016 to 2017 he was an auditor with Grant Thornton LLP. He graduated from the University of Vermont in 2015 with a Bachelors of Science in Business Administration and in 2016 with a Master of Accountancy.

Dr. Renegar joined Birchview Capital as Director of Quantitative Strategies in February 2025. Previously Nicholas ran a consulting agency, Renegar Analytics, which brought together MIT talent to build AI solutions for businesses, including development of quant signals for Birchview Capital. Before that, Nicholas was Director of Business Analytics and Operations at Yield10 Bioscience. His education background includes a PhD in Operations Research from MIT's Operations Research Center (graduated June 2021) where his thesis work focused on applications of machine learning, natural language processing, and mathematical optimization, and dual BA/BSc Degrees in Mathematics and Operations Research from Cornell University.

Mr. Strobeck is a Biotech & Med-Tech Analyst at Birchview Capital, where he models clinical and regulatory catalysts and helps shape investment decisions across the healthcare portfolio. He joined Birchview full-time in 2024 after three years in the firm's internship program, building on other internship roles at the Raptor Group and QuidelOrtho. Liam holds a B.S. in Business Administration from Saint Joseph's College of Maine and is completing his MBA at Northeastern University.

Variant Fund is a New York venture firm founded in 2020. It invests primarily at seed and selectively through Series A and growth, including liquid venture, in technology intended to expand individual autonomy. Its current investment interests include open-source infrastructure, autonomous systems, cryptography, security, new markets and regulatory policy. Its original ownership-economy strategy used blockchain networks to give users control of identity, money and data. Verified AI and deep-tech relationships include decentralized model training at Pluralis Research, GPU inference at Hyperbolic and post-quantum security at Project Eleven. Portfolio and product claims are the manager’s own statements, not independent performance validation. This manager at variant.fund is unrelated to the existing Variant Company at variant.ai, Investor3631. Its legal investment adviser is Unofficial Management, Inc., doing business as Variant (SEC CRD306409). Its legal investment adviser is Unofficial Management, Inc., doing business as Variant (SEC CRD306409).

Amina Hassan is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its michigan region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Arielle Stone is listed in Greenbrook’s current care directory as Psychiatrist, serving its michigan region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Cynthia Norscia is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its michigan region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Ingrid Martinez-Lyons is listed in Greenbrook’s current care directory as Psychiatrist, serving its michigan region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Nicholas Mischel is listed in Greenbrook’s current care directory as Regional Medical Director Michigan, serving its michigan region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Shady Shebak is listed in Greenbrook’s current care directory as Psychiatrist, serving its michigan region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Allison Hadley is listed in Greenbrook’s current care directory as Regional Medical Director Oregon, serving its oregon region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Christopher Friedlander is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its florida region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Keith Mateland is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its florida region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Rachel Frost is listed in Greenbrook’s current care directory as Psychiatrist, serving its oregon region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Shayna Loomis is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its oregon region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Clay Grimes is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its florida region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Laura Montgomery is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its florida region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Timothy Turscak is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its florida region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Whitney Lingenfelter is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its florida region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Francisco Cruz is listed in Greenbrook’s current care directory as Psychiatrist, serving its florida region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Carlos Torrellas is listed in Greenbrook’s current care directory as Psychiatrist, serving its florida region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Jacob Marion Poole is listed in Greenbrook’s current care directory as Psychiatrist, serving its florida region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Margaret Higgs is listed in Greenbrook’s current care directory as Regional Medical Director Florida, serving its florida region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Stacy Binns-Brown is listed in Greenbrook’s current care directory as Psychiatrist, serving its florida region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Stephanie Lirio is listed in Greenbrook’s current care directory as Regional Medical Director Florida, serving its florida region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Lissette Hernandez is listed in Greenbrook’s current care directory as Manager of Regional Operations, serving its florida region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Max Greger-Moser is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its connecticut region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Pamela Kurth is listed in Greenbrook’s current care directory as Medical Director, serving its connecticut region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Philip Frick is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its connecticut region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Ritu Gupta is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its connecticut region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Jenna Jeffries is listed in Greenbrook’s current care directory as Physician Assistant, serving its ohio region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Laura Steinberg is listed in Greenbrook’s current care directory as Psychiatrist, serving its ohio region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Scott Rohrbaugh is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its ohio region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Steven Spector is listed in Greenbrook’s current care directory as Regional Medical Director Connecticut, serving its connecticut region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Noah Miller is listed in Greenbrook’s current care directory as Psychiatrist, serving its ohio region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Kayla Gervich is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its missouri region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Richard Schenkelberg is listed in Greenbrook’s current care directory as Regional Medical Director Ohio, serving its ohio region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Robert H. Rifkin is listed in Greenbrook’s current care directory as Medical Director, serving its missouri region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Scott Schmitt is listed in Greenbrook’s current care directory as Medical Director, serving its ohio region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Sherifa Iqbal is listed in Greenbrook’s current care directory as Medical Director, serving its missouri region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Abraham Medaris is listed in Greenbrook’s current care directory as Medical Director, serving its missouri region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Daniel Loiterstein is listed in Greenbrook’s current care directory as Medical Director, serving its missouri region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Jyothi Mandava is listed in Greenbrook’s current care directory as Medical Director, serving its missouri region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Mary Katherine Bolles is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its texas region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Rachel Morel is listed in Greenbrook’s current care directory as Medical Director, serving its missouri region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Aida Coffey is listed in Greenbrook’s current care directory as Medical Director, serving its texas region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Cecil Roberts is listed in Greenbrook’s current care directory as Psychiatrist, serving its texas region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Emily Wu is listed in Greenbrook’s current care directory as Psychiatrist, serving its texas region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Erin Silvertooth is listed in Greenbrook’s current care directory as Medical Director, serving its texas region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Scott Elkin is listed in Greenbrook’s current care directory as Medical Director, serving its texas region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Kathleen Matthews is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its alaska region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Lelenneth Beebe is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its alaska region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Molly Nevin is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its alaska region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Zuraima Caldera is listed in Greenbrook’s current care directory as Medical Director, serving its texas region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Deborah Guris is listed in Greenbrook’s current care directory as Regional Medical Director Alaska, serving its alaska region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Stacia Guillen is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its virginia region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Victoria Tamayo-McHale is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its virginia region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Benjamin Stephens is listed in Greenbrook’s current care directory as Psychiatrist, serving its virginia region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Benjamin Crawford is listed in Greenbrook’s current care directory as Psychiatrist, serving its virginia region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Laura Worrel is listed in Greenbrook’s current care directory as Psychiatrist, serving its virginia region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Brad Berger is listed in Greenbrook’s current care directory as Psychiatrist, serving its virginia region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Seth Rosenblatt is listed in Greenbrook’s current care directory as Psychiatrist, serving its virginia region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Siddharth Bajpai is listed in Greenbrook’s current care directory as Psychiatrist, serving its virginia region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Andrew Orr is listed in Greenbrook’s current care directory as Psychiatrist, serving its virginia region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Mark Schreiber is listed in Greenbrook’s current care directory as Psychiatrist, serving its virginia region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Katharine Heatwole is listed in Greenbrook’s current care directory as Medical Director, serving its virginia region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Kevin Moore is listed in Greenbrook’s current care directory as Medical Director, serving its virginia region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Madan Uprety is listed in Greenbrook’s current care directory as Medical Director, serving its virginia region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Maria Gonzales-Vigilar is listed in Greenbrook’s current care directory as Psychiatrist, serving its virginia region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Sanju Adhikari is listed in Greenbrook’s current care directory as Medical Director, serving its virginia region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Clay Watson is listed in Greenbrook’s current care directory as PA-C, serving its south carolina region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Cyllene Saintelien is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its massachusetts region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Emily White is listed in Greenbrook’s current care directory as Senior Manager of Regional Operations, serving its virginia, ohio, connecticut, michigan regions. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

George Sotereanos is listed in Greenbrook’s current care directory as Psychiatrist, serving its south carolina region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Hannah Jones is listed in Greenbrook’s current care directory as NP/PA, serving its south carolina region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers. The published biography describes an independent-contractor relationship; this clinical affiliation does not imply full-time employment.

Chris Kalil is listed in Greenbrook’s current care directory as Manager of Regional Operations, serving its massachusetts, connecticut regions. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Coleen Harbin is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its maryland region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

David Morin is listed in Greenbrook’s current care directory as Psychiatrist, serving its massachusetts region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Karen DiCocco is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its maryland region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

William Kendall Bache is listed in Greenbrook’s current care directory as Psychiatrist, serving its massachusetts region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Allison Krichbaum is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its maryland region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Daniel Kauffman is listed in Greenbrook’s current care directory as Psychiatrist, serving its maryland region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Elle Cleaves is listed in Greenbrook’s current care directory as Psychiatrist, serving its maryland region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Robyn Blake-Manning is listed in Greenbrook’s current care directory as Nurse Practicioner, serving its maryland region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Timothy Lacy is listed in Greenbrook’s current care directory as Psychiatrist, serving its maryland region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Allen W. Kleinberg is listed in Greenbrook’s current care directory as Psychiatrist, serving its maryland region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Edward Swanton is listed in Greenbrook’s current care directory as Medical Director, serving its maryland region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Joshua Sussal is listed in Greenbrook’s current care directory as Medical Director, serving its maryland region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Lauren Elliott is listed in Greenbrook’s current care directory as Medical Director, serving its maryland region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Sawsan Ghurani is listed in Greenbrook’s current care directory as Medical Director, serving its maryland region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Hanita Chhabra is listed in Greenbrook’s current care directory as Regional Medical Director Maryland, serving its maryland region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Kaitlyn Lobozzo is listed in Greenbrook’s current care directory as Manager of Regional Operations, serving its maryland region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Misty Borst is listed in Greenbrook’s current care directory as Medical Director, serving its maryland region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Kathy Sharp is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its illinois region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Sofia Wheeler is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its illinois region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Ami Patel is listed in Greenbrook’s current care directory as Manager of Regional Operations, serving its illinois, missouri regions. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Dennis Gelyana is listed in Greenbrook’s current care directory as Psychiatrist, serving its illinois region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Keertan Reddy is listed in Greenbrook’s current care directory as Psychiatrist, serving its north carolina region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Mary Ewing is listed in Greenbrook’s current care directory as Psychiatrist, serving its north carolina region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Terry Hanusa is listed in Greenbrook’s current care directory as Regional Medical Director Illinois, serving its illinois region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Dorit Morecraft is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its north carolina region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Mark Baker is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its north carolina region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Mitchell Whigham is listed in Greenbrook’s current care directory as Physician Assistant, serving its north carolina region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Rebecca Witten Jones is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its north carolina region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Tanvir Iqbal is listed in Greenbrook’s current care directory as Psychiatrist, serving its north carolina region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Andrea Hernandez is listed in Greenbrook’s current care directory as Medical Director, serving its north carolina region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Keshavpal Reddy is listed in Greenbrook’s current care directory as Medical Director, serving its north carolina region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Kristen Gialo is listed in Greenbrook’s current care directory as Medical Director, serving its north carolina region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Michael Redmond is listed in Greenbrook’s current care directory as Psychiatrist, serving its north carolina region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Susan Myers is listed in Greenbrook’s current care directory as Psychiatrist, serving its north carolina region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Brayden Efseroff is listed in Greenbrook’s current care directory as Psychiatrist, serving its california region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

John Baldrias is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its california region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Kellie Tolin is listed in Greenbrook’s current care directory as Regional Medical Director North Carolina, serving its north carolina region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Lauren Prasek Castronovo is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its california region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Ravinder Mann is listed in Greenbrook’s current care directory as Nurse Practitioner, serving its california region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Paul Sargent is listed in Greenbrook’s current care directory as Psychiatrist, serving its california region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Samieh Askari is listed in Greenbrook’s current care directory as Psychiatrist, serving its california region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Brandon Niemeier is listed in Greenbrook’s current care directory as Psychiatrist, serving its california region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Heather Kurera is listed in Greenbrook’s current care directory as Psychiatrist, serving its california region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Sana Johnson-Quijada is listed in Greenbrook’s current care directory as Psychiatrist, serving its california region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Anthony Aichouri is listed in Greenbrook’s current care directory as Psychiatrist, serving its california region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Geoffrey Grammer is Chief Medical Officer of Neuronetics and Greenbrook Mental Wellness Centers. The parent’s July2026 announcement identifies his clinical leadership of Greenbrook’s Rockville National Center of Excellence and direct patient-care responsibilities. His work concerns interventional psychiatry and neuromodulation.

Nicole Lowry is listed in Greenbrook’s current care directory as Vice President of Operations, serving its california, north carolina, illinois, maryland, massachusetts, south carolina, virginia, alaska, texas, missouri, ohio, connecticut, florida, oregon, michigan regions. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Olivia Ellis is listed in Greenbrook’s current care directory as Senior Manager of Regional Operations, serving its california, alaska, texas, oregon regions. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Robert Zaragoza is listed in Greenbrook’s current care directory as Regional Medical Director California, serving its california region. Greenbrook provides clinical transcranial magnetic stimulation and esketamine services through its mental wellness centers.

Greenbrook TMS Inc. operates the Greenbrook Mental Wellness Centers network of interventional psychiatry clinics in the United States. Clinics provide NeuroStar transcranial magnetic stimulation and, at selected locations, SPRAVATO esketamine treatment. Its neuroscience relevance is clinical neuromodulation and psychiatric care; it is a care-delivery operator, rather than the manufacturer of NeuroStar or an AI software vendor. The Ontario legal company was incorporated in2018 around an existing US treatment-center business. Neuronetics completed its acquisition on December9,2024, making Greenbrook a wholly owned subsidiary; the Greenbrook clinical brand continues while its former public listing is historical. Current public clinical leadership includes Chief Medical Officer Geoffrey Grammer and Executive Vice President/General Manager Cory Anderson. Its live care directory lists clinicians and regional operators, including medical directors, psychiatrists, nurse practitioners and physician assistants; some clinicians also run external practices or work as contractors. Madryn financed Greenbrook through funded senior loans and convertible notes. The acquisition exchanged shares after debt conversion; that exchange is not new issuer cash.

Research Engineer at Project Eleven, identified by the company’s own public posts. He writes technical research and explanations about cryptographic decisions and digital signature security. Additional career biography and an authenticated portrait are unverified.

Advisor to Project Eleven, named in its current company roster. The issuer identifies him as founder of Applied Quantum and describes previous work at KPMG, PwC, IBM and Accenture. He advises on cybersecurity and post-quantum transition risks; an exact appointment date is not independently established.

Advisor to Project Eleven, announced in October 2025. Co-founder and former CEO of Chainalysis and co-founder of Kraken, he brings blockchain infrastructure and institutional experience. The issuer biography describes a PhD in quantum mechanics and an advisory focus on quantum readiness and crypto security. This is an advisory role, not a new executive appointment at Chainalysis.

Product Lead at Project Eleven. His own professional profile says he joined to lead the product team and describes a background in physics, product leadership and education. The company’s current roster confirms his title; an exact appointment date is unverified.

Vice President of Engineering at Project Eleven, according to its current company roster. His November 2025 joining announcement described him as Lead Engineer, responsible for core protocol architecture, migration infrastructure and engineering growth. Previously VP of Core Engineering at Notabene, with earlier work at HelloFresh, Boost and WeQ Global. His promotion date is unverified.

Biliana Pehlivanova is a recognized thought leader on Energy & Power markets and Technology & Innovation in Energy. At Macquarie's infrastructure investment arm she drove the introduction of AI and emerging technologies across the firm's global energy investments. She previously led Barclays Capital's natural gas and power research team and served as energy investment strategist at Loews Corporation. Biliana leverages her unique background in advanced technology implementation and deep commodities markets expertise to advise Mobilize on macro view for its investments.

Megan Rosengarten joined the Neuronetics board in August2021. Her background includes medical-device and consumer-product commercialization, leadership of Medtronic Surgical Robotics, global marketing at Hologic and roles at Covidien and Johnson & Johnson. She holds a UNC MBA and a Duke degree in biological anthropology and anatomy.

Eric Shaw is a Venture Partner and member of Mobilize's Investment Committee and brings over 30 years of experience in commodities markets and principal investing. Eric is currently a Managing Partner of Polar Rock Energy, an energy focused equity investor. In his prior role at RWE from 2009-2018, he established and led RWE's Principal Investments group, managing over €300 million in energy asset and equity investments. Before RWE, Eric held senior roles at Citigroup and Barclays Capital in London and New York, focusing on gas & power and principal investment transactions.

Glenn Muir is a Neuronetics director and certified public accountant with prior CFO and executive leadership at Hologic. His background includes financial reporting, public offerings and acquisition integration. He graduated from UMass Amherst and holds graduate business and taxation degrees from Harvard and Bentley.

Sasha Cucuz is a Neuronetics director and CEO of Greybrook Securities. The company biography describes his capital-markets and real-estate investment responsibilities and earlier leadership of Greybrook Health, including its role launching Greenbrook TMS. Greybrook is distinct from Greenbrook.

Sudheesh Sureshkumar is a Partner at Mobilize, based in Europe. Over his career, Sudheesh has built and commercialized both industrial grade hardware systems (e.g. wind turbines) and software platforms (AI-driven analytics and workflow automation for infrastructure investment funds). Sudheesh has also cultivated an extensive network across European startups, VC firms, universities and AI research labs, which enable him to spot promising ventures in their nascent stages. At Mobilize, Sudheesh leverages his background and network to generate exceptional deal flow and conduct rigorous technical due diligence on AI x Energy startups.

George Manahilov is the Managing Partner of Mobilize. George has an extensive career in Energy with a unique blend of experiences – from managing a Real Asset infrastructure fund (UBS Asset Management - Energy Storage Fund I), to building Energy ventures across the U.S. and Europe (Walden Green Energy, M R Power), to Commodities principal investing at global banks (Barclays Capital and Goldman Sachs). George is a recognized thought leader on topics such as battery storage, energy transition investments and real asset power infrastructure. At Mobilize, George applies his broad experience to drive investment thesis formulation and execution.

Sheryl Conley is a Neuronetics director and Audit Committee member. Her medical-device career includes Group President–Americas, global brand management and Chief Marketing Officer at Zimmer Holdings. She holds a biology and chemistry degree and an MBA from Ball State University.

Mobilize AI x Energy is a New York-based venture investor operating under the Mobilize Climate Capital identity named in portfolio-company financing announcements and SEC filings. It invests in seed through Series A companies in North America and Europe building solutions for AI's access and speed to power, electricity-grid management and energy-market intelligence. Its current portfolio includes PIQ Energy, ThreeV, Tyba, Veckta, CFEX, FuSE and Orbify. The publicly named team consists of Managing Partner George Manahilov, Partner Sudheesh Sureshkumar, Venture Partner Eric Shaw and Operating Partner Biliana Pehlivanova. Its earlier Mobilize Climate Capital website describes investing from idea validation through Series A/B across the decarbonization value chain and lists the same New York office and Berlin presence. A 2024 SEC filing identifies Mobilize Climate Capital LLC as management company of Mobilize Climate Fund I LP and Mobilize Climate Fund I GP LLC as general partner. That filing reports a $5.6 million offering target, zero interests sold and first sale yet to occur; a verified final fund close or current assets under management was not established. The team's previous energy project capacity and other managers' assets are separate from Mobilize fund size.

Rob Cascella, also identified as Robert A. Cascella, chairs the Neuronetics board and joined in April2021. His healthcare leadership includes executive roles at Philips, President and CEO of Hologic, and work at CFG Capital and NeoVision. Career acquisition and fundraising totals are not company financings.

Cory Anderson is Neuronetics EVP and General Manager of Greenbrook, effective July1,2026, after serving in technology, R&D and clinical leadership at Neuronetics. Earlier he worked at Sebacia, The Innovation Factory, Accuitive Medical Ventures and Novoste. He holds biomedical-engineering degrees from Tulane and an Emory MBA. Corporate experience or board-observer service does not establish a personal cash investment.

Rob Greene is Neuronetics SVP, Sales. The company describes approximately30years of commercial experience, including Chief Commercial Officer at EMSAR, sales leadership at Integra LifeSciences and earlier capital-equipment sales roles at GE Healthcare.

Dan Reuvers is President and CEO of Neuronetics and a member of its board, effective March23,2026. Previously he led Tactile Medical and spent12years at Integra LifeSciences, including leadership of its Codman Specialty Surgical neurosurgery business. The company directory also identifies earlier leadership at Omni-Tract Surgical, Advanced Respiratory and Vital Signs.

Nir Naor became Neuronetics CFO on July23,2026. He previously served as CFO at Axogen, Arbor Pharmaceuticals and the U.S./Americas business of Mölnlycke, with earlier finance leadership at UCB and AstraZeneca. He holds an IMD MBA and is a CFA charterholder.

Public U.S. medical technology and interventional mental-health company (Nasdaq: STIM), incorporated in Delaware in2003 and headquartered in Malvern, Pennsylvania. It develops and markets the NeuroStar Advanced Therapy transcranial magnetic stimulation system, using noninvasive magnetic pulses for prescription treatment within its cleared indications. FDA510(k) clearances cover adult major depressive disorder, anxiety symptoms accompanying adult MDD, adjunct treatment for adult obsessive-compulsive disorder, and adjunct MDD treatment for adolescents aged15–21; clearance is indication-specific. Neuronetics acquired Greenbrook TMS on December9,2024 and operates its U.S. interventional psychiatry clinic network as a wholly owned subsidiary, offering TMS and SPRAVATO therapies. Dan Reuvers became President and CEO in March2026; current leaders include CFO Nir Naor, Cory Anderson as EVP and General Manager of Greenbrook, and sales SVP Rob Greene. Its neuroscience relevance rests on neuromodulation devices, clinical evidence, patient registries and care delivery; planned neuronavigation collaborations and workflow integrations do not establish additional cleared indications. Verified financing includes venture rounds, a2018IPO, subsequent public equity offerings and actual debt draws. Madryn became a major shareholder through Greenbrook debt conversion and merger share exchange; this noncash ownership event is distinct from new issuer cash funding. Geoffrey Grammer is Chief Medical Officer of both Neuronetics and Greenbrook, as explicitly identified in the company’s July28,2026 announcement.

Head of Strategy at Project Eleven, joining in August 2025 to lead partnerships, marketing and go-to-market strategy. Previously an early Polymath employee and Head of Tokenization at the Polymesh Association, he also worked with RedSwan and authored B is for Bitcoin.

CTO and co-founder of Project Eleven. His own professional website describes him as a computer scientist and software engineer working on post-quantum cryptography. He publishes research and technical explanations on post-quantum signatures, cryptographic migrations and blockchain security.

CEO and co-founder of Project Eleven, developing post-quantum security for digital assets. He was previously CEO of Aleo and an investor at Andreessen Horowitz’s first crypto fund. A former US Army Green Beret, he earned an MBA at Stanford. The company announced his joining as founder and CEO in spring 2025.

Ana Hugener is a principal in Energize Capital’s Ventures investment team. Her work includes research, financial analysis, sourcing and portfolio support. She previously invested at Insight Partners and worked in private-equity consulting at McKinsey. Energize’s February2025 Tyba investment announcement identifies her as a board observer, distinct from a voting director.

Michael Baker co-founded Tyba and serves as its CEO, directing the company’s product and modeling work. He previously led grid analytics at Cypress Creek Renewables, developing solar, battery-storage and market-price models, and worked at Stem and EnerNOC.

Tom Thunell co-founded Tyba and serves as its COO. His background includes building energy and telecommunications businesses, with product-management and business-development work at Google’s X and Stem. He began his career in technology investment banking.

Tyler Lancaster is an Energize Capital Partner and co-head of its Ventures strategy. His investing focuses on software supporting energy infrastructure and decarbonization. Energize’s February2025 Tyba investment announcement identifies his appointment to Tyba’s board; this is an institutional representative role, not evidence of a personal angel investment.

Tyler Nisonoff co-founded Tyba and serves as its CTO. Before Tyba, he managed engineering and infrastructure teams at Asana, helping its systems support a large international customer base.

Emily Kramer co-founded MKT1 Capital with Kathleen Estreich and continues supporting its existing investment portfolio. She creates MKT1’s newsletter and Dear Marketers podcast and advises B2B companies on marketing. She previously built marketing teams at Asana, Carta, Astro and Ticketfly. MKT1’s own current profile says that as of 2026 she makes personal angel investments, while the fund focuses on existing portfolio support and follow-ons. Her advisory clients are separate from verified fund portfolio companies.

MKT1 Capital is an early-stage B2B venture investment platform co-founded by former marketing leaders Emily Kramer and Kathleen Estreich. It combines capital with hands-on marketing and go-to-market support. Its own current site says it stopped making new investments in summer 2024 and continues supporting its existing portfolio; its newsletter/advising site describes follow-on investments only. Emily now focuses on MKT1’s newsletter, advising and personal angel investing, while the fund site identifies Kathleen’s subsequent Pear affiliation. Those activities and personal checks are separate from fund investing. Published investments span AI software, developer tools, fintech, health technology and enterprise applications. The portfolio directory distinguishes Fund I from the MKT1 syndicate, which invested in Clay, Mutiny, Practice and Pulley. The founders’ February 2023 announcement reported nearly USD5M raised and a USD10M target, rather than a completed USD10M close. Fund I’s July 2025 SEC amendment reports USD5,878,530 actually sold to 149 investors with zero remaining in that offering. Its legal vehicle was formed in 2021 and first sold interests in November 2021, distinct from the founders’ stated 2022 platform launch. Belltower’s Seattle filing address and administrative GP roles do not establish a separate operating headquarters or investment staff.

InnovaHealth Partners, LP is a New York medical-technology private equity firm founded in 2016 according to its own company profile. Its principals previously invested at HealthpointCapital, a distinct predecessor business. The current public directory lists eight firm members and nine Strategic Advisors, with founders Mortimer Berkowitz III and John McCormick, Senior Partners Toby Cosgrove and Richard B. Emmitt, and Senior Advisor Ariella Golomb. Its neuroscience and deep-technology exposure includes Monteris Medical’s robotically controlled MRI-guided laser system for brain tumors and epilepsy, Route92Medical’s neurovascular thrombectomy technology, and image-guided or automated medical systems from Koelis and Radiaction. InnovaHealth led Monteris’ actual USD35M Series D equity financing announced in October 2022 and was a current lead investor named in its USD28M Series E announcement in March 2026; separate debt facilities are not InnovaHealth equity checks. Verified InnovaHealth participations are also linked to Route92Medical’s actual 2021 Series E, 2023 Series F, 2024 additional Series F extension and 2026 growth financings, preserving existing round IDs and personal investment history. Its website reports USD290M of assets across funds and co-investments, which is not a closed fund size. Sixteen actual legal private-fund and co-investment vehicles are supported by SEC Form ADV; exact closed sizes and closing dates remain undisclosed. Historical predecessor investments and outside advisory affiliations are separately qualified.

Matthew (Matt) Strobeck is a Monteris Medical director and Managing Partner at Birchview Capital. His current Birchview biography also reports two MIT graduate degrees, a University of Cincinnati doctorate and earlier Westfield Capital investment and management experience.

Mayank Taneja is Board Member at Monteris Medical. Vice president of venture investments at OSF Ventures, the corporate investment arm of OSF HealthCare. He joined the venture team in2016 and became its leader on June26,2022. He manages the investment program in devices, diagnostics, digital health and technology-enabled services. He previously supported medical-device usability studies at OSF, worked in post-market risk surveillance at Zimmer and practiced internal medicine in New Delhi. He earned a medical degree from Maulana Azad Medical College and an MBA from Ohio State University.

John McCormick is Board Member at Monteris Medical. He is Founder, Managing Director and Research Director at InnovaHealth Partners. John McCormick is published by InnovaHealth Partners as Partner and Founder. A founding partner of the medical-device specialist investment manager. His investing and operating background is published separately from personal investment tickets. His official manager biography additionally identifies research and private-equity investment oversight, earlier BPI Capital Partners, Baker Nye and World Bank research experience, and an MIT MBA and London School of Economics degree. It reports earlier governance work with MIT’s McGovern Institute for Brain Research and Whitehead Institute, without asserting these historical affiliations are current employment.

Partner at CU Healthcare Innovation Fund, responsible for fund operations and investment due diligence, and managing director of ventures and investments at CU Anschutz Innovations. His background includes founding startups, innovation work at Northwestern University and venture-capital analytics at Rockies Venture Club. He holds a PhD in biomedical engineering from Northwestern and a materials science engineering degree from Cornell. The manager lists board roles at Volnay, Sensorium, IMT and BocoBio; these do not imply personal equity checks.

Andrew Joiner is Board Member at Monteris Medical.

Senior associate at CU Healthcare Innovation Fund, also presented as Fred Lindseth on the team card. His experience includes company operations, strategic planning, business development and project management. He holds an MBA from the University of Texas at Austin. The official directory’s inconsistent LinkedIn target is omitted to avoid linking another person.

Richard Emmitt is Board Chair at Monteris Medical. Richard Emmitt is published by InnovaHealth Partners as Senior Partner. Also identified as Richard B. Emmitt by the firm. A medical-device investor with over40years of investment research, banking and principal-investing experience; the official manager biography corroborates The Vertical Group and Monteris board history, matching the existing canonical person. Sources differ on Vertical’s1988/1989 founding year; no disputed year is asserted here. The Vertical Group publishes Richard B. Emmitt as a general partner. His earlier work included healthcare investment research at Cyrus J. Lawrence and F. Eberstadt. He studied economics at Bucknell and business at Rutgers. The firm’s older portfolio-board list is historical and does not establish current independent boards.

General partner at CU Healthcare Innovation Fund, serial entrepreneur and investor. He has advised venture-capital and private-equity funds and healthcare research and provider innovation groups including Cleveland Clinic, Mass General Brigham, Ariadne Labs and CU Anschutz. The manager identifies board roles at Arrive Health, Hummingbird Healthcare, GoCheck Kids and Amplifire; no personal investment checks are inferred.

Eric Andrews is Vice President, Engineering and Operations at Monteris Medical.

Director of limited-partner relations at CU Healthcare Innovation Fund. His background includes mergers and acquisitions and corporate finance in mobile and broadband wireless, prior work at PwC across technology and other industries, and service as chairman of Children’s Hospital Colorado.

Michelle Bergstrom is Vice President, Quality and Regulatory at Monteris Medical.

Mortimer Berkowitz III is Board Member at Monteris Medical. He founded InnovaHealth Partners and serves as its President and CEO. Mortimer Berkowitz III is published by InnovaHealth Partners as Managing Partner and Founder. Medical-device private equity investor who co-founded predecessor HealthpointCapital in2002 and brings experience across investment research and portfolio-company governance.

Emily Smith is Vice President, Marketing at Monteris Medical.

General partner at CU Healthcare Innovation Fund and vice chancellor for innovation and partnerships and executive director of CU Anschutz Innovations. Her responsibilities include investing, company creation, licensing and strategic industry partnerships in AI and drug development. She previously served as deputy director of the Yale Entrepreneurial Institute and managed new ventures in Yale’s Office of Cooperative Research.

Independent strategic healthcare venture capital firm affiliated with the University of Colorado Anschutz Medical Campus in Aurora, Colorado. It invests in campus spinouts and external companies developing digital health, technology-enabled services, medical devices, diagnostics and therapeutics, and supports them through the clinical and research ecosystem of CU Anschutz, UCHealth, Children’s Hospital Colorado and CU Medicine. The university and hospitals are institutional partners and limited partners, rather than interchangeable names for this independent investor. Its portfolio includes AI-driven clinical abstraction and coding automation, precision-health data platforms, psychiatric therapeutics, minimally invasive neurosurgery and brain-science-based learning technology. The public portfolio distinguishes active, exited, partial-exit and IPO companies and identifies investments by Fund I or Fund II. Fund I closed with $50 million in committed capital on July 7, 2020. The current manager website reports over $100 million in assets under management; university biographies describe roughly $110 million across its venture funds. These aggregate figures are not assigned as the close size of Fund II. The current public investment team consists of general partners Kimberly Muller and Steven Lindseth, partner Gali Baler, director of LP relations Kevin Reidy and senior associate Fredrik (Fred) Lindseth. The manager’s precise founding year and Fund II close date and size are not publicly established by the reviewed primary sources.

Jared Hayman is Vice President, North American Sales at Monteris Medical.

Richard Tyc is Senior Vice President, Science and Technology at Monteris Medical. He co-founded the company in 1999 and co-invented its original MRI-guided laser ablation technology.

Doug Pahr is Chief Financial Officer at Monteris Medical.

Bertis develops proteomics-based diagnostics and tools for precision medicine. It measures protein biomarkers in blood to support early disease detection, including the MASTOCHECK breast cancer test, and provides PASS mass-spectrometry-based pan-omics analysis services to pharmaceutical, biotechnology and research organizations. Its DEEP platform applies deep learning to protein identification, quality control and interpretation. Through its SURF initiative, Bertis combines experimental surface-protein data with AI to discover and validate cancer cell-surface drug targets for research collaborations and licensing.

Cernel is an Aarhus software company building AI infrastructure for ecommerce product data. Its platform imports raw supplier information, structures product attributes and categories, enriches missing information, and produces multilingual descriptions, imagery and listings for different sales channels. It connects to retailers’ product-information systems and stores, synchronises catalogues in both directions and shows the reasoning and sources behind AI-generated changes so people can review results and provide feedback. Retailers and brands use it to automate product onboarding at scale, maintain consistent catalogues and prepare products for discovery by AI shopping assistants.

decipHER women develops biomarker-driven AI tools to identify the risk and biological patterns of peripartum and postpartum depression and support personalised maternal mental healthcare. It combines laboratory measurements of hormones and other biological signals with data science and clinical research, aiming to identify risk early and match care to each woman’s biology. Its own current website says the first clinical trial of its predictive tool is underway. The broader research programme studies how endocrine, immune and nervous-system changes shape women’s health.

MagiQware develops AI-powered software for the fault-tolerant quantum computing stack, focusing on magic state distillation and the optimisation of magic state factories. These factories produce resources needed to execute non-Clifford operations in universal quantum computation. Its approach combines quantum information science, reinforcement learning and software engineering to automate factory design and reduce the qubit, circuit and operational resources required. The Delft company targets quantum hardware providers and full-stack computing teams working toward practical fault-tolerant systems.

Membrion develops electro-ceramic desalination systems that continuously separate dissolved salts, metals and minerals from difficult industrial wastewater. Its membranes and integrated treatment systems help facilities recover water and valuable resources, stabilise discharge performance and expand treatment capacity within existing infrastructure. The company serves semiconductor manufacturing, metal finishing, food and beverage production and other industries facing harsh chemistries, reuse requirements and constrained wastewater capacity.

Oplane is a Malmö cybersecurity company developing AI-powered continuous threat modelling for software and cloud infrastructure. Its platform analyses code repositories, infrastructure configuration, services, data flows and trust boundaries to map system architecture and identify security threats as software changes. It reviews pull requests and provides prioritised findings and remediation guidance through developer workflows and AI coding tools. Its agentic security capabilities also examine AI agents and MCP integrations, helping engineering teams address architectural risks during development rather than relying on occasional manual threat-modelling sessions.

Rznomics is a South Korean biotechnology company developing RNA rewriting therapeutics using trans-splicing ribozymes. Its platform recognizes disease-associated RNA and replaces targeted RNA sequences with therapeutic RNA, supporting treatments for cancer and genetic or degenerative diseases. Its RZ-001 program targets hTERT-associated cancer biology in liver cancer and glioblastoma; the pipeline also includes Alzheimer’s disease and inherited retinal degeneration programs. The company develops a self-circularizing RNA platform for additional therapeutic applications.

Svante Technologies develops carbon-capture and removal equipment, including solid sorbent-based filters and modular rotary contactors that separate carbon dioxide from industrial emissions and the air. Its businesses cover filter manufacturing, carbon-capture plant engineering and digital services, plus project development and capital deployment. Svante also offers BASF’s OASE blue liquid-amine technology for customers with dilute industrial flue gas, providing different capture approaches for different emissions streams.

University of Ottawa professor listed among Svante’s advisers.

Designs industrial wastewater treatment processes and runs technology demonstrations and optimisation studies.

Founder of decipHER women with experience spanning neurobiology, immunology, clinical practice and medical evidence strategy. Her work connects endocrine biology, machine learning and clinical research to maternal mental health.

Leads financial and corporate strategy and capital planning to support company growth.

Gas-separation engineer and Svante co-founder; previously managed compact hydrogen-system development at QuestAir.

Leads scientific strategy, evidence generation and educational resources at decipHER women. Her background includes neuroscience research at the NIH and the University of Pennsylvania, followed by scientific leadership supporting rare-disease therapies.

Coordinates strategic partnerships and connects commercial relationships with internal product teams.

Industrial-projects executive with previous leadership at Canam, SNC-Lavalin and Kontron; founded gas-separation and battery technology businesses.